File size: 53,183 Bytes
b4e65c0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
1001
1002
1003
1004
1005
1006
1007
1008
1009
1010
1011
1012
1013
1014
1015
1016
1017
1018
1019
1020
1021
1022
1023
1024
1025
1026
1027
1028
1029
1030
1031
1032
1033
1034
1035
1036
1037
1038
1039
1040
1041
1042
1043
1044
1045
1046
1047
1048
1049
1050
1051
1052
1053
1054
1055
1056
1057
1058
1059
1060
1061
1062
1063
1064
1065
1066
1067
1068
1069
1070
1071
1072
1073
1074
1075
1076
1077
1078
1079
1080
1081
1082
1083
1084
1085
1086
1087
1088
1089
1090
1091
1092
1093
1094
1095
1096
1097
1098
1099
1100
1101
1102
1103
1104
1105
1106
1107
1108
1109
1110
1111
1112
1113
1114
1115
1116
1117
1118
1119
1120
1121
1122
1123
1124
1125
1126
1127
1128
1129
1130
1131
1132
1133
1134
1135
1136
1137
1138
1139
1140
1141
1142
1143
1144
1145
1146
1147
1148
1149
1150
1151
1152
1153
1154
1155
1156
1157
1158
1159
1160
1161
1162
1163
1164
1165
1166
1167
1168
1169
1170
1171
1172
1173
1174
1175
1176
1177
1178
1179
1180
1181
1182
1183
1184
1185
1186
1187
1188
1189
1190
1191
1192
1193
1194
1195
1196
1197
1198
1199
1200
1201
1202
1203
1204
1205
1206
1207
1208
1209
1210
1211
1212
1213
1214
1215
1216
1217
1218
1219
1220
1221
1222
1223
1224
1225
1226
1227
1228
1229
1230
1231
1232
1233
1234
1235
1236
1237
1238
1239
1240
1241
1242
1243
1244
1245
1246
1247
1248
1249
1250
1251
1252
1253
1254
1255
1256
1257
1258
1259
1260
1261
1262
1263
1264
1265
1266
1267
1268
1269
1270
1271
1272
1273
1274
1275
1276
1277
1278
1279
1280
1281
1282
1283
1284
1285
1286
1287
1288
1289
1290
1291
1292
1293
1294
1295
1296
1297
1298
1299
1300
1301
1302
1303
1304
1305
1306
1307
1308
1309
1310
1311
1312
1313
1314
1315
1316
1317
1318
1319
1320
1321
1322
1323
1324
1325
1326
1327
1328
1329
1330
1331
1332
1333
1334
1335
1336
1337
1338
1339
1340
1341
1342
1343
1344
1345
1346
1347
1348
1349
1350
1351
1352
1353
1354
1355
1356
1357
1358
1359
1360
1361
1362
1363
1364
1365
1366
1367
1368
1369
1370
1371
1372
1373
1374
1375
1376
1377
1378
1379
1380
1381
1382
1383
1384
1385
1386
1387
1388
1389
1390
1391
1392
1393
1394
1395
1396
1397
1398
1399
1400
1401
1402
1403
1404
1405
1406
1407
1408
1409
1410
1411
1412
1413
1414
1415
1416
1417
1418
1419
1420
1421
1422
1423
1424
1425
1426
1427
1428
1429
1430
1431
1432
1433
1434
1435
1436
1437
1438
1439
1440
1441
1442
1443
1444
1445
1446
1447
1448
1449
1450
1451
1452
1453
1454
1455
1456
1457
1458
1459
1460
1461
1462
1463
1464
1465
1466
1467
1468
1469
1470
1471
1472
1473
1474
1475
1476
1477
1478
1479
1480
1481
1482
1483
1484
1485
1486
1487
1488
1489
1490
1491
1492
1493
1494
1495
1496
1497
1498
1499
1500
1501
1502
1503
1504
1505
1506
1507
1508
1509
1510
1511
1512
1513
1514
1515
1516
1517
1518
1519
1520
1521
1522
1523
1524
1525
1526
1527
1528
1529
1530
1531
1532
1533
1534
1535
1536
1537
1538
1539
1540
1541
1542
1543
1544
1545
1546
1547
1548
1549
1550
1551
1552
1553
1554
1555
1556
1557
1558
1559
1560
1561
1562
1563
1564
1565
1566
1567
1568
1569
1570
1571
1572
1573
1574
1575
1576
1577
1578
1579
1580
1581
1582
1583
1584
1585
1586
1587
1588
1589
1590
1591
1592
1593
1594
1595
1596
1597
1598
1599
1600
1601
1602
1603
1604
1605
1606
1607
1608
1609
1610
1611
1612
1613
1614
1615
1616
1617
1618
1619
1620
1621
1622
1623
1624
1625
1626
1627
1628
1629
1630
1631
1632
1633
1634
1635
1636
1637
1638
1639
1640
1641
1642
1643
1644
1645
1646
1647
1648
1649
1650
1651
1652
1653
1654
1655
1656
1657
1658
1659
1660
1661
1662
1663
1664
1665
1666
1667
1668
1669
1670
1671
1672
1673
1674
1675
1676
1677
1678
1679
1680
1681
1682
1683
1684
1685
1686
1687
1688
1689
1690
1691
1692
1693
1694
1695
1696
1697
1698
1699
1700
1701
1702
1703
1704
1705
1706
1707
1708
1709
1710
1711
1712
1713
1714
1715
1716
1717
1718
1719
1720
1721
1722
1723
1724
1725
1726
1727
1728
1729
1730
1731
1732
1733
1734
1735
1736
1737
1738
1739
1740
1741
1742
1743
1744
1745
1746
1747
1748
1749
1750
1751
1752
1753
1754
1755
1756
1757
1758
1759
1760
1761
1762
1763
1764
1765
1766
1767
1768
1769
1770
1771
1772
1773
1774
1775
1776
1777
1778
1779
1780
1781
1782
1783
1784
1785
1786
1787
1788
1789
1790
1791
1792
1793
1794
1795
1796
1797
1798
1799
1800
1801
1802
1803
1804
1805
1806
1807
1808
1809
1810
1811
1812
1813
1814
1815
1816
1817
1818
1819
1820
1821
1822
1823
1824
1825
1826
1827
1828
1829
1830
1831
1832
1833
1834
1835
1836
1837
1838
1839
1840
1841
1842
1843
1844
1845
1846
1847
1848
1849
1850
1851
1852
1853
1854
1855
1856
1857
1858
1859
1860
1861
1862
1863
1864
1865
1866
1867
1868
1869
1870
1871
1872
1873
1874
1875
1876
1877
1878
1879
1880
1881
1882
1883
1884
1885
1886
1887
1888
1889
1890
1891
1892
1893
1894
1895
1896
1897
1898
1899
1900
1901
1902
1903
1904
1905
1906
1907
1908
1909
1910
1911
1912
1913
1914
1915
1916
1917
1918
1919
1920
1921
1922
1923
1924
1925
1926
1927
1928
1929
1930
1931
1932
1933
1934
1935
1936
1937
1938
1939
1940
1941
1942
1943
1944
1945
1946
1947
1948
1949
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
2051
2052
2053
2054
2055
2056
2057
2058
2059
2060
2061
2062
2063
2064
2065
2066
2067
2068
2069
2070
2071
2072
2073
2074
2075
2076
2077
2078
2079
2080
2081
2082
2083
2084
2085
2086
2087
2088
2089
2090
2091
2092
2093
2094
2095
2096
2097
2098
2099
2100
2101
2102
2103
2104
2105
2106
2107
2108
2109
2110
2111
2112
2113
2114
2115
2116
2117
2118
2119
2120
2121
2122
2123
2124
2125
2126
2127
2128
2129
2130
2131
2132
2133
2134
2135
2136
2137
2138
2139
2140
2141
2142
2143
2144
2145
2146
2147
2148
2149
2150
2151
2152
2153
2154
2155
2156
2157
2158
2159
2160
2161
2162
2163
2164
2165
1
00:00:01,260 --> 00:00:05,520
ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุจุญุถุฑุชู†ุง ุงู„ูŠูˆู… ุนู† ุงู„

2
00:00:05,520 --> 00:00:10,060
immunodeficiency syndrome ูˆ ุงู„ immunodeficiency

3
00:00:10,060 --> 00:00:17,340
syndrome are divided ู…ุฑุฉ

4
00:00:17,340 --> 00:00:21,500
ุฃุฎุฑู‰ ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุจุญุถุฑุชู†ุง ุงู„ูŠูˆู… ุนู† ุงู„

5
00:00:21,500 --> 00:00:25,780
immunodeficiency syndrome these are divided into

6
00:00:25,780 --> 00:00:30,720
two major categoriesู‚ุณู…ู‡ู… ุฅู„ู‰ ู‚ุณู…ูŠู† ุฃุณุงุณูŠูŠู† ุฌุงู„ู‡

7
00:00:30,720 --> 00:00:33,260
ููŠู‡ primary immune deficiency ูˆ ููŠู‡ secondary

8
00:00:33,260 --> 00:00:38,740
immune deficiency ุทุจุนุง ููŠ ูƒู„ุชุง ุงู„ุญุงู„ุชูŠู† ููŠ ุญุงู„ุงุช

9
00:00:38,740 --> 00:00:43,460
ู…ุฑุถูŠุฉ ู…ุชุจุงูŠู†ุฉ ู‡ุชุทุฑุฎ ู„ุฃู…ุซู„ุฉ ูƒุซูŠุฑุฉ ููŠ ูƒู„ ู†ูˆุน ู…ู† ู‡ุฐู‡

10
00:00:43,460 --> 00:00:52,620
ุงู„ุฃู†ูˆุงุน ุงู„ categories

11
00:00:52,620 --> 00:00:58,050
of primary immune response ุงูˆ deficiencyุทุจ ุงุญู†ุง

12
00:00:58,050 --> 00:01:01,030
ู‡ู†ุชุทู„ู‚ ููŠ ุงู„ุจุฏุงูŠุฉ ู„ู„ primary immune deficiency ุซู…

13
00:01:01,030 --> 00:01:04,310
ู‡ู†ุชู‚ู„ ุงู„ู‰ ุงู„ secondary immune deficiency ุฌุงู†ูˆ ููŠ

14
00:01:04,310 --> 00:01:08,130
ุงู„ primary immune deficiency ู‡ูŠ ุนุจุงุฑุฉ ุนู† ุนูˆุงู…ู„

15
00:01:08,130 --> 00:01:12,970
ุฃุณุงุณูŠุฉ ู„ู„ immune response ุงูˆ ุจุงู„ุชุงู„ูŠ ุจู†ุญูƒูŠ ุนู„ู‰ T

16
00:01:12,970 --> 00:01:17,410
cell ูŠุนู†ูŠ cell mediated immunity ูˆ ุจู†ุญูƒูŠ ุนู„ู‰ B

17
00:01:17,410 --> 00:01:21,070
cell ูŠุนู†ูŠ antibody mediated immunity ุจู†ุญูƒูŠ ุนู„ู‰

18
00:01:21,070 --> 00:01:28,590
both B and T cell immunityุซู… Non-specific immunity

19
00:01:28,590 --> 00:01:36,490
ู…ุชู…ุซู„ุฉ ุจุงู„ูุงุฌูˆุณูŠุชูƒ ุณูŠู„ and or ุงู†ูƒูŠ ุณูŠู„ ุซู… ุงู„

20
00:01:36,490 --> 00:01:42,490
complement activation ุฃูŠุถุง ูˆ ุทุจุนุง ูƒู„ ู‡ุฐู‡ ุงู„ุนูˆุงู…ู„

21
00:01:42,490 --> 00:01:48,190
ู…ุดุชุฑูƒุฉ ุจุชู…ุซู„ ุงู„ category of primary immune

22
00:01:48,190 --> 00:01:52,070
response ู‡ู†ุทู„ู‚ ุงู„ู‰ ูƒู„ ุนุงู…ู„ ู…ู† ู‡ุฐู‡ ุงู„ุนูˆุงู…ู„ ูˆ ู†ุงุฎุฏ

23
00:01:52,070 --> 00:01:57,100
ุฃู…ุซู„ุฉุจุฏุงูŠุฉ ู…ุง ูƒุชุด ุจุชุดูƒ ููŠ ูˆุฌูˆุฏ immunodeficiency

24
00:01:57,100 --> 00:02:05,380
ู‚ุงู„ูˆุง ููŠู‡ ุนุดุฑ ู…ุญุงุฐูŠุฑ ุฃุณุงุณูŠุฉ ู…ุธุงู‡ุฑ ุฃุณุงุณูŠุฉ for

25
00:02:05,380 --> 00:02:10,740
immunodeficiency disease ู†ู…ุฑุง ูˆุงุญุฏ six or more

26
00:02:10,740 --> 00:02:14,320
infections per year ูŠุนู†ูŠ ุฃูƒุชุฑ ู…ู† ุณุช ู…ุฑุงุช ุชุญุตู„ ููŠู‡ุง

27
00:02:14,320 --> 00:02:17,820
infection ููŠ ุงู„ุณู…ุงุก ู†ู…ุฑุง ุงุชู†ูŠู† two or more severe

28
00:02:17,820 --> 00:02:22,360
sinusitis per yearู†ู…ุฑุง ุชู„ุงุชุฉ antibiotic treatment

29
00:02:22,360 --> 00:02:27,780
lasting for two months or even longer ุจุฏูˆู† ุฃูŠุงู…

30
00:02:27,780 --> 00:02:33,900
visible effect ู†ู…ุฑุง ุฃุฑุจุนุฉ two or more pneumonia

31
00:02:33,900 --> 00:02:39,800
per year ู†ู…ุฑุง ุฎู…ุณุฉ retardation of growth and

32
00:02:39,800 --> 00:02:44,920
development of child ู†ู…ุฑุง ุณุชุฉ recurrent deep skin

33
00:02:44,920 --> 00:02:50,610
or organ abscessesู†ู…ุฑุฉ ุณุจุนุฉ ู…ูŠูƒูˆุณูŠุณ ู…ุณุชู…ุฑ ููŠ ุนู…ู„

34
00:02:50,610 --> 00:02:52,630
ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„

35
00:02:52,630 --> 00:02:56,110
ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„

36
00:02:56,110 --> 00:02:57,110
ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„

37
00:02:57,110 --> 00:02:57,130
ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„

38
00:02:57,130 --> 00:02:57,530
ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„

39
00:02:57,530 --> 00:02:57,610
ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„

40
00:02:57,610 --> 00:03:01,590
ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„

41
00:03:01,590 --> 00:03:10,320
ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู…ู„ ุนู†ู…ุฑุง ุชุณุนุฉ ุชูˆุฑ more severe

42
00:03:10,320 --> 00:03:14,740
infection ุฒูŠ encephalitis, osteitis, dermatitis,

43
00:03:14,860 --> 00:03:19,440
myositis and sepsis ู†ู…ุฑุง ุนุดุฑุฉ family history

44
00:03:19,440 --> 00:03:27,680
indicating primary immune deficiency ุทุจุนุง ููŠ ุนู†ุฏู†ุง

45
00:03:27,680 --> 00:03:32,980
ุฌุฏูˆู„ ุงู† ุดุงุก ุงู„ู„ู‡ ุงู„ุญู„ู‚ุงุช ุทู„ุน ุงู„ูŠู‡ ูˆุจูŠุจูŠู† ู„ู†ุง

46
00:03:32,980 --> 00:03:37,090
different types of infectionุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ ูƒุงู†ุช

47
00:03:37,090 --> 00:03:41,670
ุจูƒุชูŠุฑูŠุง ุงู„ู‚ุทุงุนุชุณ ู…ูŠุฏูŠุง ูˆ ุจูƒุชูŠุฑูŠุง ุงู„ู†ูˆู…ูˆู†ูŠุง ุบุงู„ุจุง

48
00:03:41,670 --> 00:03:44,470
ุจู†ุดูˆูู‡ุง ููŠ ุงู„ู†ุงุณ ุงู„ู„ูŠ ุนู†ุฏู‡ู… B cell and antibody

49
00:03:44,470 --> 00:03:49,970
deficiency ูˆ ู‡ูƒุฐุง ุฌุฏูˆู„ ู…ุตู†ู ุงู†ู‡ุง ุจุงู„ุฐุงุช ุฃู…ุฑุงุถ

50
00:03:49,970 --> 00:03:56,590
ูƒุซูŠุฑุฉ ูˆ ุบูŠุงุจ ูƒู„ ูˆุงุญุฏ ุดูˆ ุจูŠุนู…ู„ ูุฃูˆู„ ูˆุงุญุฏ B cell ุงูˆ

51
00:03:56,590 --> 00:04:01,420
B lymphocyte deficiencywhich means deficiency in

52
00:04:01,420 --> 00:04:05,600
antibody-mediated immunity ููˆู‚ ุจูŠุตูŠุฑ ููŠู‡ recurrent

53
00:04:05,600 --> 00:04:08,260
bacterial infection ูˆุชุนุชุณู…ูŠุฉ recurrent infection

54
00:04:08,260 --> 00:04:11,960
ูˆู‡ุง ูƒุฐุง T cell deficiency ูŠุนู†ูŠ cell-mediated

55
00:04:11,960 --> 00:04:15,920
immunity deficiency ุจูŠุฒูŠุฏ ุงู„ susceptibility to the

56
00:04:15,920 --> 00:04:19,460
viral fungal protozoa ูˆุงู„infection ูˆู‡ูŠ ู…ุฌู…ูˆุนุฉ

57
00:04:19,460 --> 00:04:24,820
ูƒุจูŠุฑุฉ ู…ู† ุนูŠุด ู…ู† ุงู„ุญุงู„ุงุช ุงู„ู…ุฑุถูŠุฉ ูƒู„ ูˆุงุญุฏ ู„ู‡ ุนูŠุด ู„ู‡

58
00:04:24,820 --> 00:04:27,080
ุงู„ associated disease

59
00:04:29,920 --> 00:04:32,720
ุชุฎูŠู„ ุงู†ู†ุง ู†ุจุฏุฃ ู†ุญูƒูŠ ุนู†ู‡ุง ุงู„ primary

60
00:04:32,720 --> 00:04:38,440
immunodeficiency syndromes ูŠุนู†ูŠ ุจุงุณุชุซู†ุงุก ุงู„ IGA

61
00:04:38,440 --> 00:04:42,260
deficiency ุงู„ frequency of immunodeficiency is

62
00:04:42,260 --> 00:04:48,460
very low ุญุฏุฏูˆู‡ุง ูˆุงุญุฏ ููŠ ูƒู„ ุนุดุฑ ุชู„ุงู ุฎู…ุณูŠู† ูุงู„ู…ูŠุฉ

63
00:04:48,460 --> 00:04:53,520
ู…ู†ู‡ู… associated with antibody deficiency ุนุดุฑูŠู†

64
00:04:53,520 --> 00:04:59,350
ูุงู„ู…ูŠุฉ ู…ู†ู‡ู…ุงุณูˆุด combined with deficiency ุจู…ุนู†ู‰ ุงู†ู‡

65
00:04:59,350 --> 00:05:03,850
ููŠู‡ antibody ูˆ cell-mediated immunity 18% for

66
00:05:03,850 --> 00:05:07,590
phagocystic disorders 10% for cell-mediated

67
00:05:07,590 --> 00:05:15,810
immunity alone ุงู„ููƒุฑุฉ ุงู„ู‚ุงุฏู…ุฉ P1.1ุจูŠุจูŠู† ุงู† ูƒู„ ู…ุง

68
00:05:15,810 --> 00:05:20,830
ูƒุงู† ุงู„ defect earlier ูƒู„ ู…ุง ูƒุงู† ุงู„ genetic defect

69
00:05:20,830 --> 00:05:24,830
ุงูˆ ุงู„ block ุญุฏุซ

70
00:05:24,830 --> 00:05:30,330
ููŠ ุฏุฑุงุนูŠ ุงู„ู„ู‰ ู‡ูˆ ุงู„ุฌู‡ุงุฒ ุงู„ู…ู†ุงุนู‰ ูƒู„ ู…ุง ูƒุงู† earlier

71
00:05:30,330 --> 00:05:38,850
ูƒู„ ู…ุง ูƒุงู† ุงู„ effect more severe and diseaseable

72
00:05:38,850 --> 00:05:45,160
ุดูˆููˆุง ุงู„ูุฌุฑุทุจุนุง ู‡ุฐุง figure ุงู„ู„ูŠ ุงู†ุชูˆุง ุดุงูŠููŠู† ูŠุจูŠู†

73
00:05:45,160 --> 00:05:51,460
ุงู† ุงู„ hemopoietic maturation steps for both T and

74
00:05:51,460 --> 00:05:58,400
B lymphocytes ู I ุจูŠ ุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ ุจุฏุงูŠุชู‡ุง

75
00:05:58,400 --> 00:06:04,050
lymphoid stem cellุซู… pre-cell ุซู… immature cell ุซู…

76
00:06:04,050 --> 00:06:07,970
ุงู„ mature ุจูŠู‡ lymphocytes ุงู„ู„ูŠ ุทุจุนุง ุจุนุฏู‡ุง ุจุชุฏูŠู†ุง

77
00:06:07,970 --> 00:06:12,430
different types of antibody once ุงู„ู„ูŠ ู‡ูˆ

78
00:06:12,430 --> 00:06:18,090
maturation occur to plasma cell ููŠ ูƒู„ ู…ุฑุญู„ุฉ ู…ู†

79
00:06:18,090 --> 00:06:23,570
ุงู„ู…ุฑุงุญู„ ู…ู…ูƒู† ูŠุญุตู„ ููŠู‡ defect ูˆูƒู„ ู…ุฑุญู„ุฉ ู…ู† ุงู„ู…ุฑุงุญู„

80
00:06:23,570 --> 00:06:27,950
associated with certain diseaseูˆ ูƒู„ ู…ุง ูƒุงู†ุช

81
00:06:27,950 --> 00:06:36,070
ุงู„ู…ุฑุญู„ุฉ ุฃูˆ ุงู„ุฎู„ู„ ุจุฏุฑูŠ ูƒู„ ู…ุง ูƒุงู†ุด ูƒู„ ุงู„ู…ุฑุงุญู„ ุงู„ุชูŠ

82
00:06:36,070 --> 00:06:41,710
ุชู„ูŠ ุงู„ุฎู„ู„ ุจุฏู‡ุง ุชุชุนุทู„ ูˆุจุงู„ุชุงู„ูŠ ูƒู„ ู…ุง ูƒุงู† ุงู„ disease

83
00:06:41,710 --> 00:06:45,290
more severe ู†ูุณ ุงู„ุญูƒุงูŠุฉ ุจุงู„ู†ุณุจุฉ ู„ู„ thymus ุงูˆ ุงู„

84
00:06:45,290 --> 00:06:49,750
telephocytes ู‡ูŠ ุจุชูŠุฌูŠ ุนู„ู‰ ุงู„ thymus

85
00:06:52,580 --> 00:06:59,000
ุจุนุฏ ุฐู„ูƒ ุชุธู‡ุฑ ูƒู€ mature CD4 ุฃูˆ CD8 T lymphocytes

86
00:06:59,000 --> 00:07:05,280
ูˆุทุจุนุง ุชุดุชุบู„ ูƒimmune

87
00:07:05,280 --> 00:07:10,600
cell ุงู„ู…ู‡ู… ุงู†ุชุจู‡ูˆุง ุฅู„ู‰ ุงู„ุฃุฑู‚ุงู… ุงู„ู…ูˆุฌูˆุฏุฉ ูุดูˆููˆุง

88
00:07:10,600 --> 00:07:15,600
ู‚ุณู…ูˆุง ุงู„ู…ุฑุงุญู„ ู‡ุฐู‡ ุฅู„ู‰ ุฃุฑู‚ุงู… ู…ุฎุชู„ูุฉ ูˆูƒู„ ู…ุฑุญู„ุฉ

89
00:07:15,600 --> 00:07:19,120
associated ุฒูŠ ู…ุง ู‚ู„ุชู„ูƒู… or combined with a certain

90
00:07:19,120 --> 00:07:24,000
disease ูุฑู‚ 1 ุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ ู‡ูŠูŠุนู†ูŠ ูู‰ ุจุฏุฑูŠ ุฎุงู„ุต

91
00:07:24,000 --> 00:07:27,120
ุงู„ุฎู„ุงู„ ุจูŠุตูŠุฑ ูู‰ severe compound immunodeficiency

92
00:07:27,120 --> 00:07:32,200
syndrome ุฑู‚ู… ุงุชู†ูŠู† ุจุฑุถู‡ ุจุฏุฑูŠ ุงุฏูˆุฉ ุจูŠุตูŠุฑ ูู‰

93
00:07:32,200 --> 00:07:36,000
congenital thymic aplasia ูˆุจุฑุถู‡ ู‡ุฐุง ุนุจุงุฑุฉ ุนู† ุฏูŠ

94
00:07:36,000 --> 00:07:40,020
ุฌุงุฑุณ ุณู†ุฏุฑูˆู… ูŠุนู†ู‰ ู…ุงููŠุด ุชู‰ lymphocytes ุจุชุชุตู†ุน ุงุชูˆู„

95
00:07:40,020 --> 00:07:47,480
ุฑู‚ู… ุชู„ุงุชุฉ ุงุฏูˆุฉ ุจูŠุตูŠุฑ ูู‰ skid ุงูŠุถุง ุฑู‚ู… ุงุฑุจุน ูู‰ ุงู„ B

96
00:07:47,480 --> 00:07:51,610
cell ุงุฏูˆุฉู‚ุงู„ูˆุง ุจูŠุตูŠุฑ ููŠ X-Linked E Gamma Global

97
00:07:51,610 --> 00:07:58,530
Anemia ู…ุงููŠ ูˆู„ุง Antibody ุจูŠุชูƒูˆู† ุฑู‚ู… ุฎู…ุณุฉ ู…ุงุดูŠ ู‡ุฐุง

98
00:07:58,530 --> 00:08:03,570
ู‡ูˆ ุฃู†ุง ุฑู‚ู… ุฎู…ุณุฉ ุจูŠุตูŠุฑ common variable immune

99
00:08:03,570 --> 00:08:09,670
deficiency disease ูˆ ู‡ูƒุฐุง ูƒู„ ุงู„ุญุงู„ุงุช ุงู„ู„ูŠ ู‡ูˆ ูƒู„

100
00:08:09,670 --> 00:08:16,440
ุงู„ู…ุฑุงุญู„ associated with certain diseaseู†ุจุฏุฃ ุจู€

101
00:08:16,440 --> 00:08:22,600
Severe Combined Immunodeficiency Diseases ูˆู‡ูŠ

102
00:08:22,600 --> 00:08:26,640
ุนุจุงุฑุฉ ุนู† ู‡ูŠุชุฑูˆุฌูŠู†ุณ ุฌุฑูˆุจ of disease associated or

103
00:08:26,640 --> 00:08:29,700
in which cell-mediated immunity and antibody ู„ุฃู†ู‡

104
00:08:29,700 --> 00:08:35,060
combined production are defected ุงู„ุชุงู†ูŠู† ู…ุนุทู„ูŠู†

105
00:08:35,060 --> 00:08:38,960
both humoral and cell-mediated immunity are

106
00:08:38,960 --> 00:08:44,940
defectedููŠ ุงู„ุฒู…ู† ู‡ุชุณู…ูˆู‡ุง ุงูˆ Swiss-type Aiga

107
00:08:44,940 --> 00:08:49,820
Microbial Anemia ูˆ ุงู„ู†ุงุณ ู‡ุฏูˆู„ุฉ ุนุงุฏุฉ susceptible to

108
00:08:49,820 --> 00:08:54,060
virtually every type of microbial infection, viral

109
00:08:54,060 --> 00:08:59,040
infection, bacterial infection, fungal, protozoal

110
00:08:59,040 --> 00:09:04,380
and so on ุฃุดู‡ุฑ ุงู„ุญุงุฌุงุช ุงู„ู„ูŠ ู…ู„ุญูˆุธุฉ ููŠ ู‡ุฐุง ุงู„ู†ูˆุน ู…ู†

111
00:09:04,380 --> 00:09:08,380
ุงู„ุฃู…ุฑุงุถ ู‡ูˆ Infection of Cytomegalovirus,

112
00:09:08,980 --> 00:09:16,220
Pneumocystitiscarny eye and candida ุทุจุนุง ุงู„ู†ุงุณ ุฏูˆู„

113
00:09:16,220 --> 00:09:23,260
ู…ู…ู†ูˆุน ูŠุงุฎุฏูˆุง vaccine with attenuated lymph virus

114
00:09:23,260 --> 00:09:29,700
ู„ุฃู†ู‡ it will lead to death patient have been

115
00:09:29,700 --> 00:09:32,260
classified according to the following figure or

116
00:09:32,260 --> 00:09:40,020
table ุฌุงู„ ูˆุฏูˆุง ู‚ุณู…ู‡ู… ู„ T minus B plus T minus B

117
00:09:40,020 --> 00:09:45,920
minusุฃู†ูˆุงุน ู…ุฎุชู„ูุฉ ุณู†ุชุทุฑู‚ ู„ูƒู„ ู†ูˆุน ู…ู† ู‡ุฐู‡ ุงู„ุฃู†ูˆุงุน ุจุณ

118
00:09:45,920 --> 00:09:51,980
ูŠุฌุจ ุฃู† ู†ูู‡ู… ุงู† T minus ูŠุนู†ูŠ ููŠ ุบูŠุงุจ ู„ T cell ุจูŠ

119
00:09:51,980 --> 00:09:57,500
ุจู„ุณ ูŠุนู†ูŠ ููŠ normal ุจูŠ cell ูˆู…ู…ูƒู† ูŠูƒูˆู† ููŠ ุบูŠุงุจ

120
00:09:57,500 --> 00:10:02,280
ู„ุฃู†ูƒูŠ cell ู„ู…ุง ุฃู‚ูˆู„ T minus ุจูŠ minus ูŠุนู†ูŠ ู„ุง ุจูŠ

121
00:10:02,280 --> 00:10:08,780
ูˆู„ุง T cell ู…ูˆุฌูˆุฏุฉ ูˆ ู„ู…ุง ุฃู‚ูˆู„ ุงู„ุชู†ูŠู† plusู…ุนู†ุงุชู‡

122
00:10:08,780 --> 00:10:12,080
ุงู„ู†ุงุณ ุงู„ุชุงู†ูŠุฉ ู‡ุฏูˆู„ ุนู†ุฏู‡ู… T ุณู„ ูˆB ุณู„ ู„ูƒู† ู‡ู… ุบูŠุฑ

123
00:10:12,080 --> 00:10:18,840
ุดุบุงู„ุงุก ู…ุด ุดุบุงู„ูŠู† T plus B minus it's very rare ูˆ

124
00:10:18,840 --> 00:10:23,960
they preferred treatment ุทุจุนุง ู„ุญุงู„ุงุช ู…ู† ู‡ุงู„ู†ูˆุน ุงู†ู‡

125
00:10:23,960 --> 00:10:28,460
ู†ุนู…ู„ bone marrow transplantation from an HLA

126
00:10:28,460 --> 00:10:33,660
matched sibling donor ูˆุฏู‡ ุจู‚ู‰ ูˆ ู‡ุฐู‡ ุงู„ุญุงู„ุงุช ุงูˆู„

127
00:10:33,660 --> 00:10:38,340
ุญุงู„ุฉ ู‡ูŠ T minus B plus ุงุชูู‚ู†ุง ุนู„ู‰ ุงู†ู‡ ู‡ูŠู…ุงููŠุด D

128
00:10:38,340 --> 00:10:42,000
-cell ูˆุฅู†ู…ุง ู…ุงููŠู‡ B-cell ุงู„ู…ุฑุถ ู‡ุฐุง ุนุจุงุฑุฉ ุนู† X

129
00:10:42,000 --> 00:10:49,920
-linked skid ุจูŠู…ุซู„ 40 ู„ 50% ู…ู† ุงู„ุญุงู„ุงุช ุงู„ู„ูŠ ุจู†ุญูƒูŠ

130
00:10:49,920 --> 00:10:54,000
ุนู†ู‡ุง ุงู„ mutation ุฌุงู„ู‡ ู…ูˆุฌูˆุฏ ุนู„ู‰ ุงู„ X-chromosome

131
00:10:54,000 --> 00:10:58,980
ุงู„ุฌูŠู† ุงู„ู„ูŠ ุตุงุฑ ููŠู‡ mutation ู…ูˆุฌูˆุฏ ุนู„ู‰ ุงู„ X

132
00:10:58,980 --> 00:11:05,180
-chromosome which could forgamer chain ู…ุงุดูŠ

133
00:11:06,650 --> 00:11:12,870
Gamma Chain Cytokine Receptor ูˆุทุจุนุงู‹ this Gamma

134
00:11:12,870 --> 00:11:17,230
Chain ุชู„ุนุจ ุฏูˆุฑ ูƒุจูŠุฑ ููŠ ุงู„ .. ุงู„ู„ูŠ ู‡ูˆ Signal

135
00:11:17,230 --> 00:11:22,290
Transduction ู„ุนุฏุฏ ูƒุจูŠุฑ ู…ู† ุงู„ cytokine ู…ู†ู‡ุง IL2,

136
00:11:22,390 --> 00:11:30,110
IL4, IL7, IL9, IL15ูˆุทุจุนุง ู‡ุฐู‡ ู…ุนู†ุงุชู‡ ุบูŠุจู‡ุง ุจุนู…ู„

137
00:11:30,110 --> 00:11:36,930
ุบูŠุงุจ ู„ ุงู„ function for this cytokine ูˆู‡ุฐุง ููƒุฑุฉ

138
00:11:36,930 --> 00:11:42,830
ูˆุงุถุญ ุฌุฏุง ู‡ูŠ receptor ุงู„ู„ูŠ ู‡ูˆ ุนุจุงุฑุฉ ุนู† ุฅูŠุด legend

139
00:11:42,830 --> 00:11:49,870
ู„ูƒู„ ุงู„ cytokine ู‡ุฐูˆู„ ุงู„ legend ุชุนูˆู†ูˆู‡ ู„ูƒู„ ุงู„

140
00:11:49,870 --> 00:11:55,690
cytokine ู‡ุฐูˆู„ ูู‡ูŠ ุจูŠุชูƒูˆู… ู…ู† two chain ูˆุงุญุฏุฉุชูˆ ุจูˆู„ูŠ

141
00:11:55,690 --> 00:11:58,550
ู…ุจุชุนุฏุฉ chain ูˆุงุญุฏุฉ ู…ู†ู‡ู… ุจุชู„ุนุจ ุฏูˆุฑูŠ ูƒุจูŠุฑ ููŠ ุงู„

142
00:11:58,550 --> 00:12:03,010
signal transduction ูˆู‡ูŠ ุงู„ gamma chain gamma chain

143
00:12:03,010 --> 00:12:05,690
ูˆุจุงู„ุชุงู„ูŠ ุบูŠุงุจู‡ุง ูŠุนู†ูŠ ู…ุงููŠุด signal transduction

144
00:12:05,690 --> 00:12:10,270
ูˆุจุงู„ุชุงู„ูŠ ู…ุงููŠุด transcription for this gene ู…ุงุดูŠ

145
00:12:10,270 --> 00:12:16,330
ูˆุจุงู„ุชุงู„ูŠ ูƒู„ ุงู„ function ู„ู‡ุฐู‡ ุงู„ cytokine will be

146
00:12:16,330 --> 00:12:22,950
missed ุงู„ู…ุฑุถ

147
00:12:22,950 --> 00:12:30,260
ุงู„ุชุงู†ูŠ ุงู„ witchesูŠุนู†ูŠ similar to this disease ู‡ูˆ

148
00:12:30,260 --> 00:12:34,880
ุบูŠุงุจ ุงู„ุฌุฒุก ุงู„ุชุงู†ูŠ ู…ู† ุงู„ receptor ู…ุด ูƒุจูˆู„ูŠุจูŠู† ุจุชุนุฏุฏ

149
00:12:34,880 --> 00:12:39,000
ุดูŠู†ูˆ ุงู†ู…ุง ูƒ functioning process ุงู„ู„ูŠ ู‡ูˆ ุบูŠุงุจ ุงู„ุฌุงูƒ

150
00:12:39,000 --> 00:12:44,900
ูŠูˆู… ู…ุง ูŠุตูŠุฑ ููŠู‡ ุบูŠุงุจ ู„ู„ุฌุงูƒ ุทุจุนุง ู…ุง ูŠุตูŠุฑุด ููŠู‡ ุชุบูŠุฑ

151
00:12:44,900 --> 00:12:47,440
ููŠ ุงู„ gamma ูˆู…ุชู…ุง ุชุบูŠุฑุช ุจุชุงุนุฉ ุงู„ signal

152
00:12:47,440 --> 00:12:52,190
transduction ุบูŠุงุจ ุงู„ุฌุงูƒ ุฃูŠุถุงุจุฑุถู‡ ุจุนู…ู„ ู†ูุณ ุงู„ุฃุนุถุงุก

153
00:12:52,190 --> 00:12:57,950
ูˆุจุงู„ุชุงู„ูŠ ุจูŠุตูŠุฑ ููŠู‡ ุบูŠุงุจ ู„ู„ signal transduction ู‡ุฐุง

154
00:12:57,950 --> 00:13:04,990
X-linked ูˆุงู„ Jack deficiency ู‡ูˆ ุนุจุงุฑุฉ ุนู† ุงุชุฒูˆู… ุงู„

155
00:13:04,990 --> 00:13:12,290
recessive disease ุงูŠ

156
00:13:12,290 --> 00:13:15,670
ุงุชุฒูˆู… ุงู„ recessive ู‚ู„ู†ุง ุบูŠุงุจ ุงู„ Jack ุชู„ุงุชุฉ ู‡ูˆ

157
00:13:15,670 --> 00:13:21,290
ุนุจุงุฑุฉ ุนู† Tyrosine Kinase ูˆุทุจุนุง ุบูŠุงุจุจูŠุนู†ูŠ ู…ุงููŠุด

158
00:13:21,290 --> 00:13:24,950
signal transduction ูˆูˆุฌุฏูˆุง ุงู† ุงู„ expression of

159
00:13:24,950 --> 00:13:28,530
Jack ู…ูˆุฌูˆุฏ ููŠ ูƒู„ ุงู„ hemopoietic cells ูˆุจุงู„ุชุงู„ูŠ

160
00:13:28,530 --> 00:13:33,790
ู…ุงูŠุตูŠุฑุด ููŠ maturation ู„ู„ุฎู„ุงูŠุง

161
00:13:33,790 --> 00:13:40,310
ู‡ุฐู‡ ุงู„ู†ู‚ุทุฉ ุงู„ุชุงู†ูŠุฉ T minus B minus ูˆู…ู† ุงู„ุฃู…ุฑุงุถ

162
00:13:40,310 --> 00:13:46,830
ุงู„ู…ุดุงุฑูƒุฉ ููŠ ู‡ุฐุง ุงู„ group ู‡ูˆ ุงู„ adenosine diamine

163
00:13:46,830 --> 00:13:52,160
deficiencyูˆู‡ุฐุง ุนุจุงุฑุฉ ุนู† ู†ุฒุงูŠู† ุจูŠู„ุนุจ ุฏูˆุฑ ูƒุจูŠุฑ ููŠ

164
00:13:52,160 --> 00:13:59,660
ุงู„ู€ Purine pathway ูŠู…ุซู„ 20% ู…ู† ุญุงู„ุงุช ุงู„ู€ Skid ูˆู‡ูˆ

165
00:13:59,660 --> 00:14:05,260
ุนุจุงุฑุฉ ุนู† autism recessive disease ูˆุบูŠุงุจู‡ ุจูŠุนู†ูŠ

166
00:14:05,260 --> 00:14:11,720
accumulation of toxic wastes ุจูŠุตูŠุฑ ููŠ build up ููŠ

167
00:14:11,720 --> 00:14:20,200
build up ู„ูŠุด ู„ู„ toxic waste ููŠ ุงู„ุฌุณู…ุทุจุนุง it has

168
00:14:20,200 --> 00:14:24,340
greatest impact of the immune ุนู„ู‰ ุงู„ุฌู‡ุงุฒ ุงู„ู…ู†ุงุนู‰

169
00:14:24,340 --> 00:14:29,880
ุจูŠุฃุฏู‰ ู„ู„ููŠู„ูŠุฑ ุฃูˆ both T and B cell development ุจุนุฏ

170
00:14:29,880 --> 00:14:32,260
ุชุงู†ู‰ ุงู„ู„ู‰ ู‡ูˆ purely nucleotide phosphorylase

171
00:14:32,260 --> 00:14:33,020
deficiency

172
00:14:35,470 --> 00:14:39,610
ู‡ุฐุง ุณูŠุคุฏูŠ ุฃูŠุถู‹ุง ุฅู„ู‰ ุจู†ุงุก ุชุฌุงุฑุจ ู…ู† ุฃุฌู‡ุฒุฉ ู…ุฎุงุทุฑุฉ

173
00:14:39,610 --> 00:14:47,910
ุฎุตูˆุตู‹ุง ู‡ุฐู‡ ุงู„ุฃุฌู‡ุฒุฉ ุงู„ู…ุฎุงุทุฑุฉ ุจุฅู…ูƒุงู†ู‡ุง ุชุฏู…ุฑ ู†ุธุงู…

174
00:14:47,910 --> 00:14:52,930
ุงู„ู‡ูŠูˆู„ูˆุฌูŠุง ูˆุจูŠุฃุซุฑ

175
00:14:52,930 --> 00:14:57,570
ุฃูŠุถู‹ุง ุนู„ู‰ ุงู„ู€ T-cell ูˆุจุงู„ุชุงู„ูŠ ูƒู„ ุงู„ุงู†ููˆูŠุชุดูŠูˆ

176
00:14:57,570 --> 00:15:03,470
ู…ุฏูู†ูŠู† ู†ูˆุน ุชุงู†ูŠ ุงู„ู„ูŠ ู‡ูˆ Recombinase deficiency

177
00:15:04,630 --> 00:15:09,150
ุฃูŠุถุงู‹ ุงู„ู€ Recombinase Deficiency ู†ุนุฑู ุฃู†ู‡ ููŠ

178
00:15:09,150 --> 00:15:13,610
ุงู„ุฌูŠู†ุงุช ุงู„ู…ุณุคูˆู„ุฉ ุงู„ู„ูŠ ู‡ูŠ RAG 1 ูˆ RAG 2 ู‡ู…ุง two

179
00:15:13,610 --> 00:15:16,750
important genes ู…ูˆุฌูˆุฏูŠู† ูู‰ ุงู„ู€ lymphocytes only

180
00:15:16,750 --> 00:15:21,710
ูˆุจูŠู„ุนุจูˆุง ุฏูˆุฑ ูƒุจูŠุฑ ูู‰ ุงู„ rearrangement of both

181
00:15:21,710 --> 00:15:28,950
immunoglobulin gene and TCR gene ูˆุจุงู„ุชุงู„ูŠ ุบูŠุงุจู‡ู…

182
00:15:29,520 --> 00:15:34,520
ุจูŠุคุฏูŠ ุฅู„ู‰ ุฎู„ู„ ููŠ ุงู„ู€ gene rearrangement ูˆุจุงู„ุชุงู„ูŠ

183
00:15:34,520 --> 00:15:38,600
ุงู„ู€ mutation ุจุชุคุซุฑ ุฅู„ู‰ complete absence ุชุนู…ู„

184
00:15:38,600 --> 00:15:43,440
complete absence ู„ู„ู€ T ูˆ B ุงู„ุงู†ูุณุงูŠุช ูˆุจุงู„ุชุงู„ูŠ

185
00:15:43,440 --> 00:15:44,540
ู…ุงููŠุด immunoglobul

186
00:15:50,790 --> 00:15:56,210
ูˆุจุงู„ุชุงู„ูŠ ู…ุงููŠุด match or ู„ุฃ ุชูŠ ูˆู„ุง ุจูŠ ู„ุฃู† ุงู„

187
00:15:56,210 --> 00:16:04,670
function is intact ุชูŠ ุจู„ุณ ุจูŠ ู…ุงุนูŠู† ุงุฐุง ุจูŠู‚ูˆู„ูˆุง

188
00:16:06,040 --> 00:16:10,740
ูˆู‚ุงู„ูˆุง ุงู† ุฃุดุงุฑู‡ุง ุงู„ู€ Omen Syndrome ูˆุงู„ู€ Omen

189
00:16:10,740 --> 00:16:17,280
Syndrome ุฃูŠุถู‹ุง ู‡ูˆ ุนุจุงุฑุฉ ุนู† ุฎู„ู„ ุจูŠุตูŠุฑ ููŠู‡ reduction

190
00:16:17,280 --> 00:16:21,420
ููŠ ุงู„ or partial complete or partial reduction of

191
00:16:21,420 --> 00:16:27,900
the rag genes ูˆุจุงู„ุชุงู„ูŠ ุจูŠุตูŠุฑ ููŠู‡ ุฎู„ู„ ููŠ ุงู„ rag

192
00:16:27,900 --> 00:16:32,760
activity ุงู„ clinical presentation ุฒูŠ ูˆุฒูŠ ุงู„ graft

193
00:16:32,760 --> 00:16:39,350
versus host diseaseูˆุงู„ู†ุงุณ ุฏูˆู„ุฉ ุชุฏูุน ู‡ุฐู‡ ุงู„ุชุญูƒู…ุงุช

194
00:16:39,350 --> 00:16:44,390
ู„ู„ู†ุธุงู… ุงู„ุงู†ูŠูˆู†ูŠูˆ ูˆู‡ู… ู„ุฏูŠู‡ู… ุฌุณุฏ ูƒุจูŠุฑ ุฌูŠ ุชูŠ

195
00:16:44,390 --> 00:16:51,550
ุงู†ูู„ุชุฑุงุชูŠุดู† ู…ู† ุฒูŠู†ูˆููŠู„ ูˆุงูƒุชููŠุช ุชูŠ ุณูŠู„ ุชุฏูุนู†ุง ุงู„

196
00:16:51,550 --> 00:16:57,290
ุชูŠู‡ูŠู„ุจุฑุชูˆ ุจุงุชูˆูŠ ุณุงูŠุชูˆ ูƒุงูŠู† ูˆู‡ุฐุง ุจูŠู‚ุฏุฑ ุงู„ู‡ูŠุจุฑ ุงูŠ ุฌูŠ

197
00:16:57,290 --> 00:17:00,730
ุงูŠ ุณูŠู†ุฏุฑูˆู… ูˆู…ุงู„ ู†ูŠูˆุชุฑุงุดูŠู†

198
00:17:03,450 --> 00:17:08,590
ุงู„ู…ุญุงุตู„ุฉ ู…ุฑุถู‰ ู…ู† ู‡ุฐุง ุงู„ู†ูˆุน ุจูŠุญุชุงุฌ ุงู„ู‰ pre

199
00:17:08,590 --> 00:17:14,430
-treatment with immunosuppressive drug ุงู„

200
00:17:14,430 --> 00:17:21,550
T plus B plus subgroup ูƒู„ ุงู„ุชู†ุชูŠู† ู…ูˆุฌูˆุฏูŠู† ู„ูƒู† they

201
00:17:21,550 --> 00:17:24,870
are not functioning ุฃุดู‡ุฑ ู‡ุฐู‡ ุงู„ุฃู…ุฑุงุถ ุงู„ pair

202
00:17:24,870 --> 00:17:30,040
lymphocyte syndromeุฏู‡ ู‡ูˆ ุจูŠู‚ุฏูŠ ุงู„ู‰ results from

203
00:17:30,040 --> 00:17:34,920
the failure to express HLA molecule ูˆุงู„ุณุจุจ ููŠ ุฐู„ูƒ

204
00:17:34,920 --> 00:17:37,960
ุทุจุนุง ู…ุงููŠุด HLA molecule ูŠุนู†ูŠ ู…ุงููŠุด antigen

205
00:17:37,960 --> 00:17:45,220
presentation ุจูˆุงุณุทุฉ ุทุจุนุง ุงู„ู„ูŠ ู‡ูˆ HLA class 2

206
00:17:45,220 --> 00:17:48,680
molecule deficiency ููŠ ุงู„ุบุงู„ุจ class 1 ู…ู…ูƒู† ูŠูƒูˆู†

207
00:17:48,680 --> 00:17:54,470
ู…ุชุฃุซุฑ ูˆู…ู…ูƒู† ู„ุฃcirculating T and B cell may be

208
00:17:54,470 --> 00:18:00,110
normal ู„ูƒู† ููŠ ุบูŠุงุจ ุงู„ HLA class 2 ู…ูˆู„ูŠูƒูŠูˆู„ ู…ุง

209
00:18:00,110 --> 00:18:07,180
ุจูŠุญุตู„ ููŠู‡ antigen presentation ู„ CD4 T cellุงู„ู€ ZAP

210
00:18:07,180 --> 00:18:12,080
-17 ู…ูŠูˆุชูŠุดู† ู‡ูŠ ุนุจุงุฑุฉ ุนู† ูƒูŠู…ูŠูƒุงู„

211
00:18:12,080 --> 00:18:19,620
ู…ูŠุณู†ุฌุฑ ุจูŠุนู…ู„ ู†ู‚ู„ ู„ู„ุฅุดุงุฑุฉ ุจู…ู†ุฎุฏ

212
00:18:19,620 --> 00:18:21,700
TCR ู„ู„ู†ูˆูƒู„ูŠุงุณ ูˆู‡ูˆ ู†ู‚ู„ ู„ู„ุฅุดุงุฑุฉ ุจู…ู†ุฎุฏ TCR ู„ู„ู†ูˆูƒู„ูŠุงุณ

213
00:18:21,700 --> 00:18:24,800
ูˆู‡ูˆ ู†ู‚ู„ ู„ู„ุฅุดุงุฑุฉ ุจู…ู†ุฎุฏ TCR ู„ู„ู†ูˆูƒู„ูŠุงุณ ูˆู‡ูˆ ู†ู‚ู„

214
00:18:24,800 --> 00:18:27,880
ู„ู„ุฅุดุงุฑุฉ

215
00:18:27,880 --> 00:18:31,840
ุจู…ู†ุฎุฏ TCR ู„ู„ู†ูˆูƒู„ูŠุงุณุดูˆููˆุง ู‡ุฐู‡ ุงู„ุนู„ุงู‚ุฉ ู…ุง ุฃุญู„ุงู‡ุง

216
00:18:31,840 --> 00:18:37,580
ู†ุนุฑู ุงู†ู‡ ููŠ ุนู†ุฏู†ุง antigen presenting cell ู…ุงุดูŠ

217
00:18:37,580 --> 00:18:43,160
ุจุชู‚ุฏู… ุงู„ู„ูŠ ู‡ูˆ

218
00:18:43,160 --> 00:18:47,400
telophosize

219
00:18:47,400 --> 00:18:56,040
ุงู„ antigen ู„ telophosize ูˆ ุทุจุนุงุณูˆุงุก ูƒุงู†ุช ุงู„ู€

220
00:18:56,040 --> 00:19:01,140
Antigen Presenting Cell Macrophage ุงูˆ B Cell ุชู†ุชู‡ูŠ

221
00:19:01,140 --> 00:19:05,660
ุจู‚ุฏู… ุงู„ุงู†ุชุฌูŠู† ู„ู…ู†ุŸ ู„ู€ T-Lymphocyte ุดูˆููˆุง ุงุญุชู…ุงู„ุงุช

222
00:19:05,660 --> 00:19:09,340
ุงู„ุฎู„ุงู„ ูƒูŠู ุจุชุตูŠุฑ ู‚ุจู„ ุงุญุชู…ุงู„ ูŠุตูŠุฑ ููŠู‡ ุฎู„ุงู„ ููŠ ุงู„

223
00:19:09,340 --> 00:19:13,220
MSC Class II ุจูŠุนู…ู„ ู…ุฑุถ ูŠุณู…ูˆู†ู‡ Pale Lymphocyte

224
00:19:13,220 --> 00:19:16,740
Syndrome ุญุงุฌุฉ ู†ู‚ุงู„ ู…ุชูˆู… ุงุญุชู…ุงู„ ุงู„ุฎู„ุงุฒ ูŠูƒูˆู† ููŠ ุงู„

225
00:19:16,740 --> 00:19:20,860
FAS ุงูˆ ุงู„ FAS Legend ูˆ ู‡ูŠุนู…ู„ FAS Deficiency

226
00:19:20,860 --> 00:19:27,110
Syndromeูˆ ุงุญุชู…ุงู„ ุงู„ุฎู„ู‚ ูŠูƒูˆู† ููŠ CD40 legend ูˆ CD40

227
00:19:27,110 --> 00:19:30,590
legend ู…ูˆุฌูˆุฏ ุนู„ู‰ ุงู„ T cell ุจูŠุนู…ู„ ุญุงุฌุฉ ุจูŠุณู…ูˆู‡ุง

228
00:19:30,590 --> 00:19:37,990
Hyper IgM Syndrome ุงุซุฑ

229
00:19:37,990 --> 00:19:43,150
Multi System Disorders ุจุงู„ุงุถุงูุฉ ู„ู„ skid ููŠ skid

230
00:19:43,150 --> 00:19:48,190
like clinical picture associated with certain

231
00:19:48,190 --> 00:19:52,000
disease ุฒูŠ Stuttgart-Aldrich Syndromeูˆุฏุง ุงุณู…ู‡

232
00:19:52,000 --> 00:19:56,940
syndrome ุนุจุงุฑุฉ ุนู† x-linked disease ุจูŠุชู…ุซู„ ุจุงู„ู‚ุงุชู„

233
00:19:56,940 --> 00:20:00,860
ู†ู…ุฑุง ูˆุงุญุฏ ููŠ bleeding ู„ุฃู†ู‡ ููŠู‡ thrombocytopenia

234
00:20:00,860 --> 00:20:04,340
ู†ู…ุฑุง ุงุชู†ูŠู† ููŠ recurrent bacterial infection ููŠ

235
00:20:04,340 --> 00:20:12,200
allergic reaction ููŠ long term patient ู…ู…ูƒู† ูŠุฌู„ุจ ู„

236
00:20:12,200 --> 00:20:18,680
malignant disease ูˆ ุงู„ genetic basisู†ุช ูŠุนู†ูŠ

237
00:20:18,680 --> 00:20:24,580
ู…ูŠูˆุชูŠุดู† ููŠ ุงู„ู€ X-linked gene ุงู„ู„ูŠ ุจูŠู‚ุฏู‘ูŠ ุงู„ู‰ a

238
00:20:24,580 --> 00:20:29,940
witch code for ูˆูŠุณูƒูˆุช ุฃู„ุฏุฑูŠุฎ ุณู†ุฏุฑูˆู… ุจุฑูˆุชูŠู† ูˆู‡ุฐุง

239
00:20:29,940 --> 00:20:35,400
ู…ูˆุฌูˆุฏ ููŠ ูƒู„ ุงู„ู€ hemopoietic stem cells both T and

240
00:20:35,400 --> 00:20:38,220
B cell are functionally non abnormal

241
00:20:40,700 --> 00:20:47,340
ูˆุจุงู„ุชุงู„ูŠ ู„ุง ูŠู…ูƒู† ุงู„ุดุฎุต ุงู† ูŠุชูุงุนู„ ุจู€ Polysaccharide

242
00:20:47,340 --> 00:20:51,640
Antigen ุงู„ุชุนุงู…ู„ ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ูŠุญุชุงุฌ ุฅู„ู‰ Antibiotic

243
00:20:51,640 --> 00:20:57,600
ูˆAntiviral ูˆ ุจูˆู„ู…ุงุฑูˆ ุชุฑุงู†ุณุจู„ุงู†ุชูŠุดู† ูˆ ุจุฏูˆู† ู‡ุฐุง

244
00:20:57,600 --> 00:21:02,260
ุงู„ุนู„ุงุฌ ุงู„ life expectancy ู„ุง ุชุชุนุฏู‰ ุชู„ุช ุณู†ูˆุงุช

245
00:21:02,260 --> 00:21:09,180
ุฃุชุงูƒุณูŠุง ุชู„ุงู†ุฌูƒุชุงุฒูŠุงู…ู† ุงู„ู‚ุตูŠุฑ ุจุฑุถู‡ ู…ุฑุถู‰ system

246
00:21:09,180 --> 00:21:14,320
genetic disorders ุจูŠุชู…ุซู„ ุจุงู„ู‚ุงุชู„ ุจูŠุตูŠุฑ ููŠู‡ jerky

247
00:21:14,320 --> 00:21:19,480
movement or lack of muscle coordination ูˆู†ู…ุฑ ุงุชู†ูŠู†

248
00:21:19,480 --> 00:21:24,170
abnormal vascular dilatation ุชู„ุนู†ุฌูƒุชุงุฒูŠุฉููŠ ุงู„ู€ eye

249
00:21:24,170 --> 00:21:28,570
ูˆ ุงู„ skin ูˆ ุจุฒูŠุงุฏุฉ ุงู„ susceptibility to infection

250
00:21:28,570 --> 00:21:34,870
ุจูŠุตูŠุฑ ุงู†ุฏูˆู„ู†ููˆู…ุฉ ูˆ ุงู„ defect ููŠ ุงู„ both B ูˆ T cell

251
00:21:34,870 --> 00:21:40,270
ุงู„ gene ุทุจุนุง of ataxia telangiectasia code for a

252
00:21:40,270 --> 00:21:46,490
protein known ATM ุงู„ุฃุทูุงู„ have a risk for

253
00:21:46,490 --> 00:21:51,870
developing malignancy ุฎุตูˆุตุง ุงู„ lymphoid neoplasm

254
00:21:55,810 --> 00:22:01,390
ุงู„ู€ category ุงู„ุชุงู†ูŠ ู‡ูˆ ุงู„ immune deficiency

255
00:22:01,390 --> 00:22:04,030
disorder associated with T cell and cell-mediated

256
00:22:04,030 --> 00:22:08,510
immunity ู‚ุงู„ูˆุง ุงู„ู†ุงุณ ู‡ุฏูˆู„ุฉ ู…ุด ุนู†ุฏู‡ู… T cell

257
00:22:08,510 --> 00:22:12,790
associated deficiency disease ุงู†ู‡ ุงุชูู‚ู†ุง ุนู„ู‰ ุงู† ุงู„

258
00:22:12,790 --> 00:22:19,090
T cell deficiency ู…ุงู‡ูŠุดูŠ associated with ุงู„ู„ูŠ ู‡ูˆ

259
00:22:19,090 --> 00:22:21,810
disease ุฒูŠ ุงู„ viral fungal protozoal infection

260
00:22:23,590 --> 00:22:26,890
ูˆูƒู„ู†ุง ุจู†ุนุฑู ุฅู† ุงู„ู€ T-Lymphocyte ุจุชุณุงุนุฏ ุงู„ู€ B

261
00:22:26,890 --> 00:22:30,730
-Lymphocyte ููŠ ุฅู†ุชุงุฌ ุงู„ู€ antibody which antibody

262
00:22:30,730 --> 00:22:36,430
would form T cell dependent antigen ูˆุบูŠุงุจ or T

263
00:22:36,430 --> 00:22:40,810
cell associated deficiency ู‡ูŠุนู…ู„ selective defect

264
00:22:40,810 --> 00:22:46,170
in antibody production ูˆุจุงู„ุชุงู„ูŠ T cell deficient

265
00:22:46,170 --> 00:22:51,430
patient have difficultto distinguish have

266
00:22:51,430 --> 00:22:55,850
difficulty to distinguish clinically to be

267
00:22:55,850 --> 00:23:00,270
distinguished clinically from a skeptic patient ู…ุง

268
00:23:00,270 --> 00:23:05,450
ุฒุงู„ ุงู„ B ูˆ ุงู„ T ู…ุด ู…ูˆุฌูˆุฏุฉ ูŠุจู‚ู‰ ูƒู…ุงู† ุงู„ B ู…ุด ุฑุงุญ

269
00:23:05,450 --> 00:23:09,350
ุชุดุชุบู„ Congenital

270
00:23:09,350 --> 00:23:13,890
Thymic Aplasia ุงู„ู„ูŠ ู‡ูˆ ุฏูŠุฌุงุฑุฏ ุณู†ุฏุฑูˆู… ู‚ู„ู†ุง ู‡ุฐุง ููŠ

271
00:23:13,890 --> 00:23:20,950
ู…ุฑุงุญู„ ู…ุจูƒุฑุฉ ุฌุฏุง ุจุตูŠุฑ ุงุฐุง ูุงูƒุฑูŠู† ููŠ ุฑู‚ู… ุงุชู†ูŠู†ููŠ ุงู„ู€

272
00:23:20,950 --> 00:23:26,110
T cell hemopoietic maturation steps ุงู„ู…ู‡ู… ุฏูŠ ุฌูˆุฑุฌ

273
00:23:26,110 --> 00:23:31,070
ุณู†ุฏุฑูˆู… ุจูŠุนู†ูŠ ุงู†ู‡ ููŠู‡ T cell deficiency ูˆ in which

274
00:23:31,070 --> 00:23:34,770
the cell must develop abnormally ู…ุงููŠุด ุงูŠุด ู…ุงููŠุด

275
00:23:34,770 --> 00:23:38,950
development ูŠุจู‚ู‰ ู…ุงููŠ ุฅู†ุชุงุฌ ู„ T lymphocyte no T

276
00:23:38,950 --> 00:23:46,310
cell ูˆ ู†ู‚ูˆู„ ุฅู† ุงู„ุฎู„ู„ ู†ุงุชุฌ ุนู† defective migration

277
00:23:46,310 --> 00:23:51,420
of fetal neural crest cellsุงู„ุซุงู„ุซุฉ ูˆุงู„ุชุงู„ุชุฉ

278
00:23:51,420 --> 00:23:58,280
ู…ุตุทู„ุญุงุช ุงู„ูุฑู†ุฌูŠุงู„ ูˆุจุงู„ุชุงู„ูŠ ุงู„ู…ุฑูŠุถ ุงู„ู‡ุงุฑุฏ ูˆุงู„ููŠุณ

279
00:23:58,280 --> 00:24:05,480
ูŠุชุทูˆุฑ ุจุดูƒู„ ุทุจูŠุนูŠ ูˆุจุฑุถู‡ ุงู„ุซุงูŠู…ุณ ูˆุงู„ุจุฑุงุซูŠุฑูˆูŠุฏ ู„ุง ูŠุชู…

280
00:24:05,480 --> 00:24:08,820
ุชุตู…ูŠู… ู‡ุฐุง ูŠุคุฏูŠ ุฅู„ู‰ ุซุงูŠู…ูƒ ุฃุจู„ูŠุฌูŠุง

281
00:24:08,820 --> 00:24:14,640
ูˆhypoparathyroidism ุซุงูŠู…ูƒ

282
00:24:14,640 --> 00:24:18,940
ุฃุจู„ูŠุฌูŠุง ูŠู†ุชู‡ูŠ ููŠ ู…ูุงุฌุฃุฉ ู…ุฏุฑุณุฉ ู…ุฏุฑุณุฉ ู…ุฏุฑุณุฉ ู…ุฏุฑุณุฉ

283
00:24:19,890 --> 00:24:24,170
Dudler's syndrome ู‡ูˆ ู…ุด hereditary disease ูˆุงู†ู…ุง

284
00:24:24,170 --> 00:24:31,990
ุจูŠุตูŠุฑ ููŠู‡ Sporadic deficiency in chromosome 22q11

285
00:24:31,990 --> 00:24:36,990
or deletion ุทุจุนุง ู‡ุฏูˆู„ ุงู„ู…ุฑุถู‰ ุจูŠุตูŠุฑ ููŠ ุนู†ุฏู‡ู…

286
00:24:36,990 --> 00:24:40,350
recurrent of or chronic infection with viruses

287
00:24:40,350 --> 00:24:47,810
ุจูƒุชูŠุฑูŠุง ูู†ุฌุงู‰ ุจุฑูˆุชูˆุฒูˆู‡ูˆ ูˆ ุงู„ู†ุงุณ ู‡ุฏูˆู„ ุนู†ุฏู‡ู… ู‚ูŠุงุจ ู„ู„

288
00:24:47,810 --> 00:24:54,090
T cellุฃูŠุถู‹ุง ูุดู„ุช ุชุฌุฑูŠ ุนู„ู‰ ุชุฌุงุฑุจ ุงู„ุงู†ุชุจุงู‡ ู‡ุฐู‡

289
00:24:54,090 --> 00:24:56,730
ุงู„ุฃุดุฎุงุต ู„ุง ูŠุฌุจ ุฃู† ูŠูƒูˆู†ูˆุง ู…ู…ูŠุฒูŠู† ุจูˆุงุณุทุฉ ู…ูˆุงุฌู‡ุฉ

290
00:24:56,730 --> 00:24:58,610
ู…ูˆุงุฌู‡ุฉ ู…ูˆุงุฌู‡ุฉ ู…ูˆุงุฌู‡ุฉ ู…ูˆุงุฌู‡ุฉ ู…ูˆุงุฌู‡ุฉ ู…ูˆุงุฌู‡ุฉ ู…ูˆุงุฌู‡ุฉ

291
00:24:58,610 --> 00:25:02,910
ู…ูˆุงุฌู‡ุฉ ู…ูˆุงุฌู‡ุฉ ู…ูˆุงุฌู‡ุฉ

292
00:25:03,160 --> 00:25:06,740
with normal peripheral T cell number ูŠุนู†ูŠ ููŠู‡

293
00:25:06,740 --> 00:25:12,140
normal T lymphocyte ู„ูƒู† ููŠ ู†ูุณ ุงู„ูˆู‚ุช ูุดูŠ ูุดูŠ

294
00:25:12,140 --> 00:25:17,960
function ุงุฏู‰ functional defect ูู‰ T cell ุงูŠุถุง

295
00:25:17,960 --> 00:25:22,260
opportunistic infection and high incidence of

296
00:25:22,260 --> 00:25:27,140
autoimmune disease ู…ู„ุงุญุธุงุช it's autosomal

297
00:25:27,140 --> 00:25:32,200
recessive pattern ูˆุทุจุนุง ู‡ูˆ ุนุจุงุฑุฉ ุนู† heterogeneous

298
00:25:32,200 --> 00:25:38,880
groupุฃูŠุถุง ูŠุดู…ู„ ุบูŠุงุจ ู„ู„ ZAP-17 ุชูŠุฑูˆุฒูŠู†ูƒูŠู†ูŠุฒ CD3E

299
00:25:38,880 --> 00:25:45,860
ูˆCD3G ู‡ูˆ ู‡ุฐู‡ ุงู„ู…ูˆู„ูŠูƒูŠูˆู„ ุงู„ู…ุชุนู„ู‚ุฉ ุจุงู„ุฅุดุนุงุฑ T-cell

300
00:25:45,860 --> 00:25:55,840
ูˆุจุงู„ุชุงู„ูŠ ู…ุงููŠุด ูุงู†ูƒุดู Autoimmune

301
00:25:55,840 --> 00:26:01,920
lymphoproliferative disease ุงูˆุฃูŠุถุงู‹ ุฅู†ู‡ุง ุชุณู…ู‰ ุจู€

302
00:26:01,920 --> 00:26:06,300
Inherited by Massive Proliferation of Lymphoid

303
00:26:06,300 --> 00:26:08,980
Tissue ูˆุจุฏุฃุช

304
00:26:08,980 --> 00:26:27,160
ูŠุชุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุทุท

305
00:26:32,150 --> 00:26:35,050
ุนุงู…ู„ ุงู„ู€ autoimmune lymphoproliferative ุงู„ุดุฎุตูŠุฉ ุฃูˆ

306
00:26:35,050 --> 00:26:43,170
ุงู„ุดุฎุตูŠุฉ ุงู„ุณูŠู†ุงู…ูŠุฉ ู„ุฏูŠู‡ุง ู…ูŠูˆุชูŠุดู† ููŠ ุงู„ู€ FAS ุฌูŠู†

307
00:26:43,170 --> 00:26:51,870
ูŠุชุนุงู…ู„ ู…ุน ุงู„ู€ FAS ุจุฑูˆุชูŠู† CD95 ูŠุชุนุงู…ู„ ู…ุน ุงู„ู€

308
00:26:51,870 --> 00:27:00,350
Apoptosis signaling ู„ุฏูŠู‡ู… ูˆุงุญุฏ ุทุจูŠุนูŠ ูˆูˆุงุญุฏ ู…ูŠูˆุชูŠุช

309
00:27:00,350 --> 00:27:07,140
FAS ู…ูˆู„ูŠูƒูˆู„ูˆู‡ุฐุง ุจูŠุคุฏูŠ ุงูˆ that mutated phase

310
00:27:07,140 --> 00:27:11,140
molecule interfere with the function of normal

311
00:27:11,140 --> 00:27:15,780
molecule ุทุจุนุง ุงู„ mutated ู‡ูˆ ุงู„ู„ูŠ ุจูŠุชุฏุฎู„ ููŠ ุงู„

312
00:27:15,780 --> 00:27:20,420
function of normal molecule these patients have

313
00:27:20,420 --> 00:27:25,840
defect in other component of apoptosis pathway ุฒูŠ

314
00:27:25,840 --> 00:27:29,120
ุงู„ phase ligand or case base 10

315
00:27:31,670 --> 00:27:37,270
Chronic Mucocutaneous Candidiasis ุจูŠู‡ ู…ู† ุงู„ุงุณู…

316
00:27:37,270 --> 00:27:42,250
Candidiasis ูŠุนู†ูŠ ููŠู‡ Candida infection of skin and

317
00:27:42,250 --> 00:27:47,830
mucous membrane ุบุงู„ุจุง ุงู„ู…ุฑุถู‰ have normal T cell

318
00:27:47,830 --> 00:27:52,070
mediated immunity to microorganism other than

319
00:27:52,070 --> 00:27:56,810
Candida and normal B cell mediated immunityto all

320
00:27:56,810 --> 00:28:04,190
microorganism ุจู…ุง ููŠู‡ุง ุงู„ Canada ูŠุนู†ูŠ ุงู„ุฎู„ู„ ููŠ

321
00:28:04,190 --> 00:28:09,210
ุงูŠู‡ุŸ ููŠ ุงู„ T-lymphocyte which can respond to all

322
00:28:09,210 --> 00:28:12,930
ุงู„ micro part ู…ุน ุงู„ Canada ุจูŠู†ู…ุง ุงู„ B-lymphocyte

323
00:28:12,930 --> 00:28:17,350
is normal they have selective defect in the

324
00:28:17,350 --> 00:28:20,210
functional of T cell

325
00:28:23,500 --> 00:28:28,520
ุงู„ุชุงู†ูŠ ู‡ูˆ ุงู„ BCL-R immunoglobulin associated

326
00:28:28,520 --> 00:28:33,400
immunodeficiency ูˆุฃุดู‡ุฑ

327
00:28:33,400 --> 00:28:36,980
ู…ุซุงู„ ุนู„ู‰ ุฐู„ูƒ ุจุฑูˆุชูˆู† ุงูŠ ุฌุงู…ุง ุบู„ูˆุจูŠู„ุงู†ูŠู†ูŠุง ูˆู‡ูˆ ุนุจุงุฑุฉ

328
00:28:36,980 --> 00:28:42,340
ุนู† X-linked infantile ุงูŠ ุฌุงู…ุง ุบู„ูˆุจูŠู„ุงู†ูŠู†ูŠุง ุงู„ุฃุทูุงู„

329
00:28:42,340 --> 00:28:48,260
ู…ู† Infanta ุงู„ุฃุทูุงู„ present with serious unrepeated

330
00:28:48,260 --> 00:28:52,390
infectionูˆุณุจุจ ููŠ ุฐู„ูƒ is severe depression or

331
00:28:52,390 --> 00:28:56,710
virtual absence of all immunoglobulin ู†ุญู†ุง ุจู†ุญูƒูŠ

332
00:28:56,710 --> 00:29:00,890
ุนู„ูŠู‡ุง protons ูŠุนู†ูŠ ู…ุงููŠุด ุจูŠ ุณู„ ู…ุงููŠุด ุงูŠุด ุจูŠ

333
00:29:00,890 --> 00:29:06,650
lymphocyte ู…ุนู†ุงุชู‡ ู…ุงููŠุด antibody production ุทุจุนุง

334
00:29:06,650 --> 00:29:11,250
ุงู„ major defect ูˆุฌุฏูˆู‡ ุงู†ู‡ ููŠ ุนุฏู… ู‚ุฏุฑุฉ ุงู„ุจูŠุช ุงู†ู‡ุง

335
00:29:11,250 --> 00:29:19,290
ุชุฌู„ุจ to be mature as B cell protons ุฌูŠู†

336
00:29:20,990 --> 00:29:28,470
ุชู… ุชุบูŠูŠุฑู‡ ุจุทุฑูŠู‚ุฉ X ู…ุฑุชุจุทุฉ ู‡ุฐู‡

337
00:29:28,470 --> 00:29:33,710
ุงู„ุฌูŠูˆุงู†ุงุช ุชุฏุนู‰ ุชูŠุฑูˆุฒูŠู† ูƒูŠู†ูŠุฒ ุงู†ุฒุนูŠู… ู…ูˆุฌูˆุฏ ููŠ

338
00:29:33,710 --> 00:29:39,150
ุงู„ู€Cytosol XLA

339
00:29:39,150 --> 00:29:44,810
ุชู… ุชุญูŠุทู‡ ู„ุนู‚ู„ ุนู‚ู„ูŠ ุงู„ู…ุชูˆุณุท ุงู„ู…ุชูˆุณุท

340
00:29:44,810 --> 00:29:46,210
ุงู„ู…ูˆุฌูˆุฏ ููŠ ุงู„ู€Cytoplasmic

341
00:29:49,190 --> 00:29:53,930
Patient suffered repeated infection Treatment ุทุจุนุง

342
00:29:53,930 --> 00:29:57,490
Periodic injection of intravenous gamma globulin

343
00:29:57,490 --> 00:30:04,670
ุจูŠุญุชูˆูŠ ุนู„ู‰ IgG Transient

344
00:30:04,670 --> 00:30:10,990
Hypo Gamma Globulinemia ุงุณู… Transient ููŠ ุนู…ุฑ ุฎู…ุณุฉ

345
00:30:10,990 --> 00:30:16,940
ู„ุณุช ุดู‡ูˆุฑุจูŠุตูŠุฑ ููŠู‡ Passively transferred from

346
00:30:16,940 --> 00:30:26,980
maternal to fetus of IgG antibody ูˆุทุจุนุง

347
00:30:26,980 --> 00:30:36,140
ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ุจูŠุจุฏุฃ ุงู„ IGG ุจูŠุจุฏุฃ ูŠุธู‡ุฑ

348
00:30:36,140 --> 00:30:44,810
ุงู„ู„ูŠ ู‡ูˆ ุงู„ infant IGG premature infantู…ู…ูƒู† ูŠุตูŠุฑ

349
00:30:44,810 --> 00:30:49,570
ุนู†ุฏู‡ Transient IgG Deficiency if they are not yet

350
00:30:49,570 --> 00:30:55,050
able to synthesize immunoglobulin sometimes helper

351
00:30:55,050 --> 00:30:59,630
T cells are deficient ูŠุนู†ูŠ ุจูŠุตูŠุฑ ููŠู‡ ุบูŠุงุจ ููŠ ุงู„ T

352
00:30:59,630 --> 00:31:04,030
lymphocyte help ูˆุจุงู„ุชุงู„ูŠ ู…ุงููŠุด Antibody production

353
00:31:04,030 --> 00:31:08,070
ุฃูˆ B cell functioning ูŠุนู†ูŠ ู…ุงููŠุด ุดูŠุก this disease

354
00:31:08,070 --> 00:31:10,310
may persist for a few months ูˆ

355
00:31:12,600 --> 00:31:17,900
ุจุงู„ูƒุชูŠุฑ ู„ุบุงูŠุฉ ุณู†ุชูŠู† it's not x-linked and should

356
00:31:17,900 --> 00:31:24,240
be distinguished from x-linked disease ุฎู„ุงู„ ูˆุฌูˆุฏ

357
00:31:24,240 --> 00:31:29,460
ุงู„ normal number of B cells immunization should

358
00:31:29,460 --> 00:31:33,800
not be given during this period common variable

359
00:31:33,800 --> 00:31:38,120
immunodeficiency ู…ู† ุงู„ุฅุณู… it's characterized by

360
00:31:38,120 --> 00:31:39,280
ุบูŠุงุจ

361
00:31:43,570 --> 00:31:51,510
ู…ุงุดูŠ ุงูˆ reduction ููŠ ุงู„ serum IgG ูˆ IgA ูˆ ุจูŠูƒูˆู† ููŠ

362
00:31:51,510 --> 00:31:57,890
ุนู†ุฏู‡ IgM normal ุงูˆ low ูˆ ุทุจุนุง ููŠ normal ุงูˆ low

363
00:31:57,890 --> 00:32:03,950
ุจุฑูุฑ ุงู„ B cell number ุงู„ B cell fails to mature

364
00:32:03,950 --> 00:32:09,650
into plasma cellูˆุงู„ู…ุฑุถู‰ have recurrent respiratory

365
00:32:09,650 --> 00:32:13,550
and gastrointestinal infection treatment by

366
00:32:13,550 --> 00:32:22,850
intravenous immunoglobulin selective

367
00:32:22,850 --> 00:32:29,160
immunoglobulin deficiencyุงู„ู€ IgA-Deficiency ุบุงู„ุจุง

368
00:32:29,160 --> 00:32:31,860
ู…ุฑุถู‰ ุจุณ ูŠูƒูˆู† ุนู†ุฏู‡ู… recurrent viral or bacterial

369
00:32:31,860 --> 00:32:35,300
infection, celiac disease, defective absorption

370
00:32:35,300 --> 00:32:39,060
and repel ุงู„ู„ูŠ ู‡ูˆ ุนุจุงุฑุฉ ุนู† ุงู„ู€ celiac or maybe

371
00:32:39,060 --> 00:32:43,720
entirely asymptomaticุŒ treatment ุจุฏู‡ pro-the

372
00:32:43,720 --> 00:32:47,360
spectrum antibioticุŒ IgM-DeficiencyุŒ rare

373
00:32:47,360 --> 00:32:52,300
disorders ูˆุทุจุนุงุงู„ู…ุฑุถู‰ ุจูŠุนุงู†ูˆุง ู…ู† recurrent and

374
00:32:52,300 --> 00:32:54,740
severe infection with polysaccharide antigen

375
00:32:54,740 --> 00:32:59,840
-encapsulated organism ุฒูŠ pneumonia ุฃูˆ pneumococci

376
00:32:59,840 --> 00:33:05,040
and hemophilus inflammation ุงู„ disorders of T and

377
00:33:05,040 --> 00:33:11,780
B interaction ุฒูŠ ุงู„hyper IgM syndrome ูˆู‡ูˆ ุนุจุงุฑุฉ ุนู†

378
00:33:11,780 --> 00:33:18,150
hyper X-linked hyper IgM syndromePresent with

379
00:33:18,150 --> 00:33:22,530
recurrent respiratory infection ู…ู† ุฃูˆู„ ุณู†ุฉ ุฅู„ู‰

380
00:33:22,530 --> 00:33:27,670
ุณู†ุชูŠู† ู…ู† ุงู„ุนู…ุฑ ู…ูŠุชูŠุดู† ู…ูˆุฌูˆุฏุฉ ููŠ CD40-ligand ุฌูŠู†

381
00:33:27,670 --> 00:33:32,010
ุงู„ู…ูˆุฌูˆุฏ ุนู„ู‰ ุงู„ุฅูƒุณูŠ ูƒุฑูˆู…ุฒูˆู… ุงู„ู„ูŠ ูŠุจู‚ู‰ ุจูŠู‚ุฏูŠ ุฅู„ู‰

382
00:33:32,010 --> 00:33:37,890
CD40-ligand ูˆุจุงู„ุชุงู„ูŠ ููŠ ุงู„ุดูŠุก

383
00:33:40,910 --> 00:33:45,050
ุณูŠุฌู†ุงู„ ุชุฑุงู†ุฒุฏูƒุดู† ูŠุนู†ูŠ ู…ุงููŠุด ูุงู†ูƒุดู† CD40 ู„ุฌู† ุจุฑุช

384
00:33:45,050 --> 00:33:50,390
ุจุฑุช ู…ุน CD40 ู…ูˆุฌูˆุฏ ุนู„ู‰ ุณุทุญ ุจูŠ ู„ูŠู†ููˆุณุงูŠุช ูˆุทุจุนุง this

385
00:33:50,390 --> 00:33:57,810
interaction rescue the B cell from apoptosis X

386
00:33:57,810 --> 00:34:00,990
-linked lymph proliferative disease Duncan

387
00:34:00,990 --> 00:34:08,070
syndrome ูˆู‡ุฐู‡ ุจูŠุตูŠุฑ ููŠ ุนุฏู… ู‚ุฏุฑุฉ ุนู†ุฏ ุงู„ T cell to

388
00:34:08,070 --> 00:34:13,700
regulate B cell growthู‡ูˆ ุจูŠุนุชุจุฑ major part of the

389
00:34:13,700 --> 00:34:19,820
underlying disease

390
00:34:19,820 --> 00:34:24,220
ูŠุนู†ูŠ this mechanism deficiency ู‡ูˆ ุงู„ุฃุณุงุณ ููŠ

391
00:34:24,220 --> 00:34:29,730
ุงู„ู…ูˆุถูˆุน ุงู„ lymphoma incidence is highูˆุงู†ุชู‚ู„ ู„ู„ู€

392
00:34:29,730 --> 00:34:35,090
phagocytic function ูู‚ุท

393
00:34:35,090 --> 00:34:40,930
ู„ู„ุชุฐูƒูŠุฑ ุงู„ูุงุฌูˆุณูŠุชูƒ ูุงู†ูƒุดู† ูŠุนู†ูŠ ุฅุฐุง ูƒุงู† ููŠู‡ ุฎู„ู„ ููŠ

394
00:34:40,930 --> 00:34:48,910
ุฎุทูˆุงุช ุงู„ูุงุฌูˆุณูŠุชุณ ูู‚ุท ู„ู„ุชุฐูƒูŠุฑ ุงู„ูุงุฌูˆุณูŠุชุณ ุฎุทูˆุงุช

395
00:34:48,910 --> 00:34:54,620
ุงู„ูุงุฌูˆุณูŠุชุณ ู‡ูŠ ุฃุฏู‡ูŠุฌูŠู†ุซู… ุงู„ diabetes ุซู… ุงู„

396
00:34:54,620 --> 00:35:00,340
chemotaxis ุซู… ุงู„ูุงุฌูˆ ุณุงูŠุชูˆุณูŠุซ ุซู… ุงู„ killing ูˆ

397
00:35:00,340 --> 00:35:07,080
ุงู„ุชุงู„ูŠ ููŠ ุบูŠุงุจ ููŠ ูƒู„ ู…ุฑุญู„ุฉ ู…ู† ุงู„ู…ุฑุงุญู„ ู‡ุฐู‡ ูŠุคุฏูŠ ู„ู‡ุง

398
00:35:07,080 --> 00:35:11,280
ูƒู„ ู…ุฑุญู„ุฉ is combined or is associated with certain

399
00:35:11,280 --> 00:35:18,460
disease ู…ุงุดูŠ ุงุฐุง ุตุงุฑ ููŠู‡ ุจุฑุถู‡ ุงู„ุฎู„ู„ ู…ุถุฑูŠ ู…ุนู†ุงุชู‡ ูƒู„

400
00:35:18,460 --> 00:35:22,550
ุงู„ู…ุฑุงุญู„ ุงู„ู„ูŠ ู‚ุฏ ุชู„ูŠู‡ุง ูˆุงู‚ูุฉูˆุฅุฐุง ูƒุงู† ุงู„ุฎู„ู„ ุญุฏุซ

401
00:35:22,550 --> 00:35:27,990
ู…ุซู„ู‹ุง ู…ุซู„ู‹ุง ููŠ ุงู„ู„ุงุฏ ู…ุซู„ู‹ุง ู…ุซู„ู‹ุง ู…ุซู„ู‹ุง ู…ุซู„ู‹ุง ู…ุซู„ู‹ุง

402
00:35:27,990 --> 00:35:29,070
ู…ุซู„ู‹ุง ู…ุซู„ู‹ุง ู…ุซู„ู‹ุง ู…ุซู„ู‹ุง ู…ุซู„ู‹ุง ู…ุซู„ู‹ุง ู…ุซู„ู‹ุง ู…ุซู„ู‹ุง

403
00:35:29,070 --> 00:35:32,470
ู…ุซู„ู‹ุง ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู†

404
00:35:32,470 --> 00:35:33,030
ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู†

405
00:35:33,030 --> 00:35:37,450
ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู†

406
00:35:37,450 --> 00:35:43,450
ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู† ู…ุซู„ู†

407
00:35:44,920 --> 00:35:49,480
LAD ู‡ูˆ ุจุฑู†ุงู…ุฌ group of disorders ุจูŠุชู…ูŠุฒ ู…ู† ุจูŠุตูŠุฑ

408
00:35:49,480 --> 00:35:52,560
ููŠู‡ ุฎู„ู„ ููŠ ุงู„ interaction ู…ุง ุจูŠู† ุงู„ leukocyte ู…ุน

409
00:35:52,560 --> 00:36:00,660
ุงู„ vascular endothelial cells ูˆ ุทุจุนุง ู‡ุงูŠ ุงู„ู…ุฑุงุญู„

410
00:36:00,660 --> 00:36:04,700
ุทุจุนุง ุฌุงู„ูˆุง ููŠู‡ ุงูƒุชุฑ ู…ู† ู…ุฑุญู„ุฉ ู„ู„ LAD disease ูˆ

411
00:36:04,700 --> 00:36:09,240
ู‚ุณู…ูˆู‡ุง ู„ุชู„ุช ู…ุฑุงุญู„ LAD 1, LAD 2, LAD 3 ูˆ ุฒูŠ ู…ุง

412
00:36:09,240 --> 00:36:13,400
ุงู†ุชูˆุง ุดุงูŠููŠู† ููŠ LAD 1 ุจูŠุตูŠุฑ ููŠู‡ ุฎู„ู„ ููŠ ุงู„ diabetes

413
00:36:15,830 --> 00:36:20,730
ููŠ ุงู„ู‡ุฏ ุงุชู†ูŠู† ุจูŠุตูŠุฑ ููŠู‡ ุฎู„ู„ ููŠ ุงู„ adhesion ููŠ ุงู„ู‡ุฏ

414
00:36:20,730 --> 00:36:23,330
ุงู„ุชู„ุงุชุฉ ุจูŠุตูŠุฑ ููŠู‡ ุฎู„ู„ ููŠ ุงู„ activation ุงู„ู„ูŠ ู‡ูŠ

415
00:36:23,330 --> 00:36:27,450
ุงู„ูุงุฌูˆ ุณูŠุชูˆุณุณ ุจูŠุตูŠุฑ ููŠู‡ุง ุฎู„ู„ ู…ุงุดูŠ ุงู„ูŠูˆู… ุจูŠุตูŠุฑ ููŠู‡

416
00:36:27,450 --> 00:36:33,290
ุฎู„ู„ ููŠ ูˆุงุญุฏ ุงู„ู„ูŠ ู‡ูŠ ุงู„ adhesion ุฃูˆู„ ูˆุงุญุฏุฉ ุจูŠุตูŠุฑ

417
00:36:33,290 --> 00:36:38,130
ููŠู‡ ุฎู„ู„ ููŠ ูƒู„ ู‡ุฐู‡ ุงู„ู…ุฑุงุญู„ ู…ุงุดูŠ ูุงู„ูŠูˆู… ุจูŠุตูŠุฑ ููŠู‡

418
00:36:38,130 --> 00:36:41,270
ุฎู„ู„ ููŠ ุฃุฎุฑ ูˆุงุญุฏุฉ ุงู„ู„ูŠ ู‡ูŠ ุงู„ activationุทุจุนุง ุจูŠุญุตู„

419
00:36:41,270 --> 00:36:51,110
ููŠู‡ ุฃู…ุฑุงุถ ุฒูŠ ุงู„ู€ Chediac Higashi Syndrom ูˆCDD ู‡ุงูŠ

420
00:36:51,110 --> 00:36:53,510
ุงู„ู„ูŠ ู‡ุงุฏ ูˆุงุญุฏ ุญุถุฑ ุนู† ุงู„ู€ autosomal recessive

421
00:36:53,510 --> 00:36:58,870
disease ู…ู‡ุงุจูŠู†ุฌ ุชูˆ ูƒุฑูˆู…ูˆุฒูˆู…ุงู†ูˆู… 22 ุงู„ู…ุฑุถู‰ ุนู†ุฏู‡ู… ุงู„

422
00:36:58,870 --> 00:37:03,690
effect ุงู† ู‡ุชูƒูˆู† subunits of integrin molecule ูˆู‡ุฐุง

423
00:37:03,690 --> 00:37:09,210
ุจูŠู‚ุฏูŠ ุฅู„ู‰ ุงู„ู„ูŠ ู‡ูˆ ุงู†ู‡ adhesion to feel adhesion

424
00:37:09,210 --> 00:37:12,740
and migrationof all white blood cells in the army

425
00:37:14,860 --> 00:37:18,980
ููŠ ุงู„ุฃุฏูˆุงุญ ุงู„ู…ุฑุถู‰ ูŠุญุตู„ ุนู†ุฏู‡ู… current soft tissue

426
00:37:18,980 --> 00:37:22,760
bacterial infection ูˆูŠุฒูŠุฏ ุงู„ูˆู‚ุช blood cell count

427
00:37:22,760 --> 00:37:27,540
ู„ูƒู† ุจุฏูˆู† bus formation ูŠุนู†ูŠ ู…ุงููŠ activity ูˆู…ุงููŠุด

428
00:37:27,540 --> 00:37:31,060
ูƒู„ ุงู„ุฃุฎู…ุงุช ุงู„ู„ูŠ ูˆุฑุง ุงู„ adhesion ุงูˆ ุงู„ effecting

429
00:37:31,060 --> 00:37:35,140
wound healing lymphocyte function is also affected

430
00:37:35,140 --> 00:37:39,500
due to the lack of lymphocyte functioning antigen

431
00:37:39,500 --> 00:37:44,860
one expressionุงู„ู€ Add to ู‚ู„ู†ุง ุจูŠุตูŠุฑ ููŠู‡ defect in

432
00:37:44,860 --> 00:37:50,180
selecting ุงู„ู€ legend ูˆุงู„ู€ underlying defect ุงู„ู„ูŠ

433
00:37:50,180 --> 00:37:54,400
ู‡ูˆ Add to ุจูŠุตูŠุฑ

434
00:37:54,400 --> 00:37:58,700
ููŠู‡ ุฃูŠุถู‹ุง ุฎู„ุงู„ ุงู„ููŠู„ู… ููŠูˆูƒูˆุฒ ู…ุชุน Polism ูˆุฏู‡ ุจูŠู‚ุฏ

435
00:37:58,700 --> 00:38:03,140
ุฅู„ู‰ ุบูŠุงุจ ููŠูˆูƒูˆุฒ ู„ูŠุช ุงู„ legend for selecting to be

436
00:38:03,140 --> 00:38:08,560
bind ูˆุฏู‡ ู…ุซู„ ุฃูˆ ุตูˆุฑุฉ ุญู„ูˆุฉ ู„ู‡ุฐุง ุงู„ู…ูˆุถูˆุน ุงู„ุงุฏ ูˆุงุญุฏ

437
00:38:08,560 --> 00:38:18,290
ููŠ ุงู„ุดูŠุกู‡ูŠ ุนุจุงุฑุฉ ุนู† ุงุชูŠุฌูŠู†ู…ุงุดูŠ ู„ุฏ ุงุชู†ูŠู† ุนุจุงุฑุฉ ุนู†

438
00:38:18,290 --> 00:38:24,270
rolling Selected ุชูƒูˆู† ุบูŠุฑ ุฑู‚ู… ุชู„ุงุชุฉ ุงู„ู„ูŠ ู‡ูˆ ุงู„

439
00:38:24,270 --> 00:38:31,110
activation is defected ุทุจุนุง ู‡ุฐุง ูƒู„ู‡ ููŠ ู„ุฏ ูˆุงุญุฏ ุจุณ

440
00:38:31,110 --> 00:38:36,070
ููŠู‡ ุฎู„ุงู„ ููŠ ุงู„ุงุฑุชุจุงุท ูˆ ุงู„ transmigration ุงู„ู„ูŠ ู‡ูˆ

441
00:38:45,690 --> 00:38:52,590
ุงู†ุชุฌุฑุงู†ูŠุงู„ ุงูˆ ุฃูˆุฑูŠุฌุงู†ูŠู„ูŠ ุจูŠุตูŠุฑ

442
00:38:52,590 --> 00:38:57,750
ููŠ ุนู†ุฏู‡ุง ู‚ู„ุฉ ููŠ ุงู„ interest of the organism ูˆ this

443
00:38:57,750 --> 00:39:00,470
results in

444
00:39:02,700 --> 00:39:11,060
ูุงุฌูˆุฒูˆู… ูุฑู…ุดูŠ ุฃูˆ ูุงุฌูˆุฒูˆู… ูุฑู…ุดูŠ ุงูˆ

445
00:39:11,060 --> 00:39:11,740
ูุงุฌูˆุฒูˆู… ูุฑู…ุดูŠ ุงูˆ ูุงุฌูˆุฒูˆู… ูุฑู…ุดูŠ ุงูˆ ูุงุฌูˆุฒูˆู… ูุฑู…ุดูŠ ุงูˆ

446
00:39:11,740 --> 00:39:17,280
ูุงุฌูˆุฒูˆู… ูุฑู…ุดูŠ ุงูˆ ูุงุฌูˆุฒูˆู… ูุฑู…ุดูŠ ุงูˆ ูุงุฌูˆุฒูˆู… ูุฑู…ุดูŠ ุงูˆ

447
00:39:17,280 --> 00:39:22,200
ูุงุฌูˆุฒูˆู… ูุฑู…ุดูŠ ุงูˆ ูุงุฌูˆุฒูˆู…

448
00:39:23,380 --> 00:39:26,020
ู…ุฎู„ูˆู‚ ูƒุจูŠุฑ ู…ู† ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚

449
00:39:26,020 --> 00:39:27,180
ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚

450
00:39:27,180 --> 00:39:30,020
ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚

451
00:39:30,020 --> 00:39:31,620
ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚

452
00:39:31,620 --> 00:39:33,240
ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚

453
00:39:33,240 --> 00:39:38,680
ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚

454
00:39:38,680 --> 00:39:40,940
ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚

455
00:39:40,940 --> 00:39:46,160
ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚ ุงู„ู…ุฎู„ูˆู‚

456
00:39:48,980 --> 00:39:53,040
ูˆุจุงู„ุชุงู„ูŠ ุจูŠุญุตู„ ููŠู‡ ุนู…ู„ูŠุฉ phagocytosis ู„ูƒู† ู…ุงููŠู‡

457
00:39:53,040 --> 00:39:57,600
killing ูˆุจูŠุญุตู„ ููŠู‡ intracellular survival

458
00:39:57,600 --> 00:40:03,060
ูุงู„organism ุจูŠุคุฏูŠ ู„granuloma formation ู…ูŠูˆุชูŠุดู†

459
00:40:03,060 --> 00:40:06,380
ูˆุฌุฏูˆู‡ุง ููŠ ุงู„ enzymes which catalyzes the

460
00:40:06,380 --> 00:40:10,800
respiratory burst ูˆุจูŠุญุตู„

461
00:40:10,800 --> 00:40:17,120
ููŠู‡ ู‚ู„ุฉ ููŠ ุงู„intracellular killing ู…ุญุตู„ุฉ ุงูˆ ุบูŠุงุจ

462
00:40:19,320 --> 00:40:22,700
ูˆุจู†ู„ุงุญุธ ู‡ุฐู‡ ุงู„ุญุงู„ุงุช ููŠ ุฃูˆู„ ุดู‡ุฑ ุฃูˆ ุฃูˆู„ ุณู†ุชูŠู† ู…ู†

463
00:40:22,700 --> 00:40:31,400
ุงู„ุนู…ุฑ ุจูŠุตูŠุฑ ุนู†ุฏู‡ recurrent infection ุญุชู‰ ุฃุถุนู ุงู„

464
00:40:31,400 --> 00:40:35,660
microbes ู…ุฑุฉ

465
00:40:35,660 --> 00:40:40,720
ุฃุฎุฑ interferon ุฌุงู…ุน receptor deficiency ุจูŠุตูŠุฑ ููŠู‡

466
00:40:40,720 --> 00:40:43,900
mutation ููŠ ุงู„ interferon ุนุงุฆู„ุฉ ุฃุฎุฑู‰ ู…ู† ุนุงุฆู„ุงุช ุงู„

467
00:40:43,900 --> 00:40:48,030
receptorุจูŠุคุฏูŠ ุงู„ู‰ inability of a monocyte to

468
00:40:48,030 --> 00:40:53,450
respond to Gamma Interferon ูˆุจุงู„ุชุงู„ูŠ

469
00:40:53,450 --> 00:40:56,430
ููŠ ุงู„secretion of the tumor necrosis factor Alpha

470
00:40:56,430 --> 00:41:01,850
ุงู„ patient are susceptible to weakly pathogenic

471
00:41:01,850 --> 00:41:03,290
mycobacteria

472
00:41:06,330 --> 00:41:10,090
ู‡ูˆ ุงู„ู€ Natural Killer Cell Deficiency ุงู„ู„ูŠ ู†ุนุฑูู‡

473
00:41:10,090 --> 00:41:15,130
ุจูŠุงุจ ุงู„ู€ Anky cell ุจูŠุคุฏูŠ ุงู„ู‰ ุงู„ู€ Impaired

474
00:41:15,130 --> 00:41:19,090
Allograft Rejection ู…ููŠุด ุดูŠุก ุงู„ู€ Impairment

475
00:41:19,090 --> 00:41:24,930
Rejection And is linked to higher susceptibility

476
00:41:24,930 --> 00:41:29,170
to viral disease ูˆ ุจูŠุตูŠุฑ ููŠู‡ metastasis from tumor

477
00:41:31,140 --> 00:41:36,500
ุงู„ู€ Ankyl cells seen in Skid some T and phagocytic

478
00:41:36,500 --> 00:41:40,540
cell disorder and in X-linked lymphoprotective

479
00:41:40,540 --> 00:41:47,360
syndrome ุงู„ุฃูˆุฑุงู‚

480
00:41:47,360 --> 00:41:56,880
ุงู„ู„ูŠ ุจุชุชุนู„ู‚ ุจุงู„ complement ูŠุนู†ูŠ ุงู„ ..ุงู„ู€

481
00:41:56,880 --> 00:42:00,180
complement component ุงู„ุฃูˆู„ุงู†ูŠุฉ ู…ู‡ู…ุฉ ุฌุฏู‹ุง for

482
00:42:00,180 --> 00:42:07,300
obsolete ุฒูŠ C3P ุบุงู„ุจู‹ุง deficiency of complement is

483
00:42:07,300 --> 00:42:14,700
associated with SLE disease ูˆู‡ูŠ ุงู„ complement

484
00:42:14,700 --> 00:42:22,740
ูŠุฃุณูƒูŠ ุจู…ูŠูƒุงู†ุฒู… classical ูˆ alternative ุทุจุนู‹ุง

485
00:42:22,740 --> 00:42:32,270
ุฒูŠ ู…ุง ุงู†ุชูˆุง ุดุงูŠููŠู†ุงู„ู„ูŠ ู‡ูˆ ุณูˆุงุก ูƒุงู† alternative ุงูˆ

486
00:42:32,270 --> 00:42:38,110
lectin pathway ุงูˆ even classical ุบูŠุงุจู‡ุง ุจูŠุฏูŠ ู„ุฏูŠู‡ุง

487
00:42:38,110 --> 00:42:42,330
diseases ู…ุฎุชู„ูุฉ ูููŠ ุงู„ุจุฏุงูŠุฉ infections with

488
00:42:42,330 --> 00:42:46,630
encapsulated microorganismุจู‚ุฏู… ุดูˆูŠุฉ robotoid

489
00:42:46,630 --> 00:42:51,190
disease ูˆุงุณุฆู„ ุงูŠู‡ ุชุญุช ุงุฐุง ูƒุงู† ููŠ ุงู„ู…ุงูƒ ุงูˆ ุงู„

490
00:42:51,190 --> 00:42:56,830
memory attack complex ุจุตูŠุฑ ููŠู‡ ู†ูŠุณูŠุฑูŠุง ุฌู†ูˆุฑูŠุฉ ุงูˆ

491
00:42:56,830 --> 00:43:03,260
ู†ูŠุณูŠุฑูŠุง ู…ููƒุดุฉุฃูŠ ู…ุฑูŠุถ ุจู€ Deficiency of C1,4,2 ุงู„ู„ูŠ

492
00:43:03,260 --> 00:43:07,160
ู‡ูˆ ุงู„ุจุฏุงูŠุงุช ู…ู† ุงู„ู€ Classical Pathway ุฃูˆ C3

493
00:43:07,160 --> 00:43:11,100
Deficiency ู†ูุณู‡ุง ุจูŠุตูŠุฑ ููŠู‡ ุฒูŠุงุฏุฉ ููŠ ุงู„ู€ Infection

494
00:43:11,100 --> 00:43:14,180
ุฃูˆ ุงู„ู€ Encapsulated Microorganism ุญุณุจ ุงู„ุฌุฏูˆู„ ุงู„ู„ูŠ

495
00:43:14,180 --> 00:43:18,080
ุดูˆูู†ุงู‡ ุทูˆูŠ ุฒูŠ Streptococcus pneumonia ูˆ ุงู„ู€ Biogen

496
00:43:18,080 --> 00:43:24,720
ูˆ ุงู„ุงู†ูู„ูˆู†ุฒุง ูˆ ุฃุฒู…ุฉ ุฑูˆู…ุงู†ุณูŠุฉ ุจุณุจุจ ุชู†ุธูŠู ุบูŠุฑ ุตุญูŠุญ

497
00:43:24,720 --> 00:43:25,480
ู„ู„ู…ุนุงู…ู„ุงุช ุงู„ุงู…ูŠูˆู†ูŠุฉ

498
00:43:29,040 --> 00:43:33,640
ุงู„ู€ Deficiency of the man knows by the lectin

499
00:43:33,640 --> 00:43:38,100
ุจูŠุฃุฏู‰ ุงู„ู‰ ุทุจุนุง ุงู„ู…ูˆุฌูˆุฏ ุนู„ู‰ ุงู„ surface of microbe

500
00:43:38,100 --> 00:43:45,040
with or without antibody and activate the

501
00:43:45,040 --> 00:43:50,240
classical pathwayุฃูŠุถู‹ุง ุจูŠุคุฏูŠ ุบูŠุงุจู‡ ุฅู„ู‰ risk of

502
00:43:50,240 --> 00:43:56,380
infection and SLE-like symptoms ุบูŠุงุจ C3 associated

503
00:43:56,380 --> 00:44:04,700
with symptoms ุฎุตูˆุตู‹ุง ุงู„ complications ุชุจุนุชู‡ุง ุบูŠุงุจ

504
00:44:04,700 --> 00:44:08,480
ุงู„ lead complement component ููŠ ุงู„ุขุฎุฑ ูŠุนู†ูŠ ุงู„ MAC

505
00:44:08,480 --> 00:44:14,160
ุฒูŠ C56789 ุงู„ู„ูŠ ุจูŠูƒูˆู†ูˆุง ุงู„ MAC ุงู„ู„ูŠ ู‡ูˆ membrane

506
00:44:14,160 --> 00:44:21,270
attack complexIt's directly related to the primary

507
00:44:21,270 --> 00:44:27,010
defect against gram-negative bacteria ุฎุตูˆุตุง

508
00:44:27,010 --> 00:44:30,450
ู†ูŠุณูŠุฑูŠุงDefective

509
00:44:30,450 --> 00:44:34,010
control of the complement component ูŠุนู†ูŠ ุญุชู‰ ุงู„

510
00:44:34,010 --> 00:44:37,930
control ุงุฐุง ุตุงุฑ ููŠู‡ deficiency ุฒูŠ ุงู„ hereditary

511
00:44:37,930 --> 00:44:43,850
angioedema ู…ุดู‡ูˆุฑุฉ ูƒุชูŠุฑ ุบูŠุงุจ C1 esterase inhibitor

512
00:44:45,150 --> 00:44:51,370
ุจูŠุฏู‰ ุงู„ู‰ ุงู„ู„ู‰ ู‡ูˆ ุงู„ hereditary angioedema ุทุจุนุง

513
00:44:51,370 --> 00:44:54,590
ูƒู…ูŠุฉ ูƒุจูŠุฑุฉ ู…ู† ุงู„ vasoactive peptide patient

514
00:44:54,590 --> 00:44:59,370
suffering from localized edema ูˆ it's life

515
00:44:59,370 --> 00:45:03,850
threatening when it occurs in the larynx ุงู‡ ุทุจุนุง

516
00:45:03,850 --> 00:45:07,230
ุจูŠุตูŠุฑ ููŠู‡ ุงุด edema ููŠ ุงู„ larynx ูˆ ุงู„ุชุงู†ู‰ ุจูŠุตูŠุฑ ููŠู‡

517
00:45:07,230 --> 00:45:12,730
obstruction ู„ู„ airway pathway treatment

518
00:45:12,730 --> 00:45:19,410
ุบุงู„ุจุงavoid trauma and infusion of C1 esterase

519
00:45:19,410 --> 00:45:25,350
inhibitor.ุงู„ุฌู„ูŠูƒูˆุฒูŠู† ุงู„ูุณูุฉ ุฏูŠ ุงู„ enacetol protein

520
00:45:25,350 --> 00:45:33,270
deficiency ู†ุนุฑู ุงู† ู‡ุฐุง ุจู„ุนุจ ุฏูˆุฑ ูƒุจูŠุฑ ููŠ ุงู„ as

521
00:45:33,270 --> 00:45:35,670
anchored protein

522
00:45:37,690 --> 00:45:44,190
ู‡ุฐุง ุนุจุงุฑุฉ ุนู† ุนุงุฆู„ุฉ ู…ู† ุงู„ุจุฑูˆุชูŠู†ุงุช ูˆุงู„ุฌู„ูŠูƒูˆุฒูŠู‡

523
00:45:44,190 --> 00:45:48,530
ุงู„ููˆุณูุงุช ุฏูŠุงู„ ุงู„ู†ุงุณูŠุชูˆู‡ ุงู„ุงู†ูƒูˆู„ุงุช is expressed ุนู„ู‰

524
00:45:48,530 --> 00:45:51,110
ุงู„ membrane of RBCs lymphocyte granulocyte

525
00:45:51,110 --> 00:45:54,590
endothelial cell and epithelial cell ู…ุนุธู… ุงู„ุฎู„ุงูŠุง

526
00:45:55,790 --> 00:45:58,450
ุทุจุนุง DC protein ู‡ู… ุนุจุงุฑุฉ ุนู† ุงู„ุจุฑูˆุชูŠู†ุงุช ุญู…ุงูŠุฉ

527
00:45:58,450 --> 00:46:02,930
ู„ู„ุฎู„ุงูŠุง ู…ู† ุงู„ complement activity ูˆุจุงู„ุชุงู„ูŠ ุบูŠุงุจู‡ู…

528
00:46:02,930 --> 00:46:12,770
ูŠุคุฏูŠ ุฅู„ู‰ ุบูŠุงุจ ุงู„ destruction of cell ุทุจุนุง

529
00:46:12,770 --> 00:46:20,730
ูƒู„ ุงู„ุฎู„ุงูŠุง ุชุชุฃุซุฑ ููŠ ู‡ุฐุง ุงู„ู…ูˆุถูˆุน ูˆุจุงู„ุชุงู„ูŠ the ุฃูŠุถุง

530
00:46:22,580 --> 00:46:26,300
ุจูŠุตูŠุฑ ููŠู‡ hemolysis for all these cells ุทุจุนุง ุฃุดู‡ุฑ

531
00:46:26,300 --> 00:46:29,800
ู‡ุฐู‡ ู„ู„ุบุงูŠุฉ ุงู„ู„ูŠ ู‡ูˆ ุงู„ PNH ููŠ ุงู„ PNH ุทุจุนุง ุงู„

532
00:46:29,800 --> 00:46:33,760
patient ุจูŠุตูŠุฑ ููŠู‡ ุบูŠุงุจ ู„ู„ enzyme required for

533
00:46:33,760 --> 00:46:39,840
production of GBI ุงู„ู„ูŠ ู‡ูˆ ูˆุจุงู„ุชุงู„ูŠ ู…ุงููŠุด GBI ุนู†ูƒู…

534
00:46:39,840 --> 00:46:43,680
ุงู„ protein ูˆุจุงู„ุชุงู„ูŠ ู…ุงููŠุด ุจุฑูˆุชูŠู†ุงุช ุญู…ุงูŠุฉ ุนุดุงู† ู‡ูŠูƒ

535
00:46:43,680 --> 00:46:50,200
ุจุฒูŠุฏ ุงู„ susceptibility to hemolysisููŠ ุงู„ู€ Chronic

536
00:46:50,200 --> 00:46:53,580
course of B.N.H. Intravascular Hemolysis or CARE

537
00:46:53,580 --> 00:46:59,060
ุทุจุนุง ููŠ ุงู„ูƒุฏู†ู‰ ูˆู‡ุฐุง ุจูŠู‚ุฏู‰ ุงู„ู‰ ุงู„ู„ู‰ ู‡ูˆุง activation

538
00:46:59,060 --> 00:47:03,700
of complement ูŠุนู†ู‰ ูู‰ degeneration ู„ู„ุชุดูˆ ุฃูˆ damage

539
00:47:03,700 --> 00:47:08,740
ู„ู„ุชุดูˆ ูˆู†ุชูˆู‚ู

540
00:47:08,740 --> 00:47:12,520
ู‡ู†ุง ู„ู†ุณุชูƒู…ู„

541
00:47:12,520 --> 00:47:14,220
ูู‰ ู…ุฑุญู„ุฉ ู‚ุงุฏู…ุฉ ุงู† ุดุงุก ุงู„ู„ู‡